Int64Index: 65 entries, 14 to 12911 memory usage: 4.1+ KB
count null dtype
column
WkD_disease 65 non-null object
WkD_diseaseLabel 65 non-null object
WP_en_article 65 non-null object
class 65 non-null object
importance 65 non-null object
taskForces 65 non-null object
cochrane_reviews_html 65 non-null object

Table Guide:

Grouping:

In cases, where there are multiple version of a Cochrane review, they are grouped toghther (showing the same background color) ,and are listed chronologically,latest version first.

Color Codes:

  1. Green: up-to-date and CITED

  2. Red: up-to-date and NOT CITED

  3. Orange: out-of-date and CITED

  4. Grey: out-of-date and NOT CITED

Results Table contains 65 rows

WkD_disease WkD_diseaseLabel WP_en_article class importance taskForces cochrane_reviews_html
index
4412 Q12192 pneumonia Pneumonia GA 1-Top

Pulmonology
  1. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. PMID: 25835432 [CITED] [LATEST Version]
  2. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. PMID: 16856118 [NOT CITED] [LATEST Version]
  3. Antibiotic therapy versus no antibiotic therapy for children aged two to 59 months with WHO-defined non-severe pneumonia and wheeze. PMID: 24859388 [NOT CITED] [LATEST Version]
  4. Antibiotics for community acquired pneumonia in adult outpatients. PMID: 19821292 [NOT CITED] [LATEST Version]
  5. Antibiotics for community acquired pneumonia in adult outpatients. PMID: 15106168 [NOT CITED] [OLD Version]
  6. Antibiotics for community acquired pneumonia in children. PMID: 16856067 [NOT CITED] [LATEST Version]
  7. Antibiotics for community-acquired pneumonia in adult outpatients. PMID: 25300166 [CITED] [LATEST Version]
  8. Antibiotics for community-acquired pneumonia in children. PMID: 23733365 [CITED] [LATEST Version]
  9. Antibiotics for community-acquired pneumonia in children. PMID: 20238334 [NOT CITED] [OLD Version]
  10. Antibiotics for preventing pneumonia in children with measles. PMID: 11034721 [NOT CITED] [LATEST Version]
  11. Antibiotics for preventing pneumonia in children with measles. PMID: 10908500 [NOT CITED] [OLD Version]
  12. Antibiotics for preventing pneumonia in children with measles. PMID: 10796647 [NOT CITED] [OLD Version]
  13. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. PMID: 23076916 [NOT CITED] [LATEST Version]
  14. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. PMID: 16856106 [NOT CITED] [OLD Version]
  15. Antibiotics for treating community-acquired pneumonia in people with sickle cell disease. PMID: 27841444 [NOT CITED] [LATEST Version]
  16. Antibiotics for ventilator-associated pneumonia. PMID: 27763732 [CITED] [LATEST Version]
  17. Chest physiotherapy for pneumonia in adults. PMID: 23450568 [CITED] [LATEST Version]
  18. Chest physiotherapy for pneumonia in adults. PMID: 20166082 [NOT CITED] [OLD Version]
  19. Chest physiotherapy for pneumonia in children. PMID: 30601584 [CITED] [LATEST Version]
  20. Chest physiotherapy for pneumonia in children. PMID: 24057988 [CITED] [OLD Version] [UPDATE NEEDED]
  21. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. PMID: 23076954 [CITED] [LATEST Version]
  22. Corticosteroids for pneumonia. PMID: 29236286 [CITED] [LATEST Version]
  23. Corticosteroids for pneumonia. PMID: 21412908 [NOT CITED] [OLD Version]
  24. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. PMID: 18254049 [NOT CITED] [LATEST Version]
  25. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. PMID: 15846713 [NOT CITED] [OLD Version]
  26. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. PMID: 22972070 [CITED] [LATEST Version]
  27. Granulocyte colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. PMID: 14584011 [NOT CITED] [LATEST Version]
  28. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. PMID: 17443546 [CITED] [LATEST Version]
  29. Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. PMID: 15266532 [NOT CITED] [OLD Version]
  30. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. PMID: 24615270 [NOT CITED] [LATEST Version]
  31. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. PMID: 16625618 [CITED] [LATEST Version]
  32. Oral care measures for preventing nursing home-acquired pneumonia. PMID: 30264525 [CITED] [LATEST Version]
  33. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. PMID: 27778318 [NOT CITED] [LATEST Version]
  34. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. PMID: 23939759 [NOT CITED] [OLD Version]
  35. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. PMID: 24615334 [CITED] [LATEST Version]
  36. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. PMID: 22336815 [NOT CITED] [OLD Version]
  37. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. PMID: 17943884 [NOT CITED] [OLD Version]
  38. Oxygen therapy for pneumonia in adults. PMID: 22419316 [CITED] [LATEST Version]
  39. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. PMID: 15495133 [NOT CITED] [LATEST Version]
  40. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. PMID: 19821336 [CITED] [LATEST Version]
  41. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. PMID: 28116747 [CITED] [LATEST Version]
  42. Post-pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults. PMID: 26241698 [CITED] [LATEST Version]
  43. Probiotics for preventing ventilator-associated pneumonia. PMID: 25344083 [NOT CITED] [LATEST Version]
  44. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PMID: 25269391 [CITED] [LATEST Version]
  45. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. PMID: 17636808 [NOT CITED] [OLD Version]
  46. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. PMID: 25354013 [NOT CITED] [LATEST Version]
  47. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. PMID: 22258968 [NOT CITED] [OLD Version]
  48. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. PMID: 18843718 [NOT CITED] [OLD Version]
  49. Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation. PMID: 26743945 [NOT CITED] [LATEST Version]
  50. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. PMID: 18425930 [CITED] [LATEST Version]
  51. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months. PMID: 29020436 [NOT CITED] [LATEST Version]
  52. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months. PMID: 26077639 [NOT CITED] [OLD Version]
  53. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. PMID: 30188565 [NOT CITED] [LATEST Version]
  54. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. PMID: 26301604 [CITED] [LATEST Version]
  55. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. PMID: 21975771 [NOT CITED] [OLD Version]
  56. Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients. PMID: 26266942 [NOT CITED] [LATEST Version]
  57. Surfactant for bacterial pneumonia in late preterm and term infants. PMID: 22336836 [NOT CITED] [LATEST Version]
  58. Vitamin A for non-measles pneumonia in children. PMID: 16034908 [CITED] [LATEST Version]
  59. Vitamin C for preventing and treating pneumonia. PMID: 23925826 [CITED] [LATEST Version]
  60. Vitamin C for preventing and treating pneumonia. PMID: 17253561 [NOT CITED] [OLD Version]
  61. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia. PMID: 30024634 [CITED] [LATEST Version]
  62. Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age. PMID: 21975768 [CITED] [LATEST Version]
  63. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. PMID: 27915460 [CITED] [LATEST Version]
  64. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. PMID: 21154362 [NOT CITED] [OLD Version]
12873 Q47912 lung cancer Lung cancer FA 1-Top

Pathology

Pulmonology
  1. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. PMID: 25730344 [CITED] [LATEST Version]
  2. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. PMID: 28756617 [NOT CITED] [LATEST Version]
  3. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. PMID: 23152201 [NOT CITED] [LATEST Version]
  4. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. PMID: 16625532 [NOT CITED] [OLD Version]
  5. Biomedical risk assessment as an aid for smoking cessation. PMID: 30912847 [NOT CITED] [LATEST Version]
  6. Biomedical risk assessment as an aid for smoking cessation. PMID: 23235615 [NOT CITED] [OLD Version]
  7. Biomedical risk assessment as an aid for smoking cessation. PMID: 19370604 [NOT CITED] [OLD Version]
  8. Biomedical risk assessment as an aid for smoking cessation. PMID: 16235375 [NOT CITED] [OLD Version]
  9. Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer. PMID: 20464750 [CITED] [LATEST Version]
  10. Chemotherapy and surgery versus surgery alone in non-small cell lung cancer. PMID: 17636828 [CITED] [LATEST Version]
  11. Chemotherapy for advanced non-small cell lung cancer in the elderly population. PMID: 26482542 [CITED] [LATEST Version]
  12. Chemotherapy for brain metastases from small cell lung cancer. PMID: 22696370 [NOT CITED] [LATEST Version]
  13. Chemotherapy for non-small cell lung cancer. PMID: 10796867 [CITED] [LATEST Version]
  14. Chemotherapy versus best supportive care for extensive small cell lung cancer. PMID: 24282143 [NOT CITED] [LATEST Version]
  15. Chemotherapy versus best supportive care for extensive small cell lung cancer. PMID: 19821287 [NOT CITED] [OLD Version]
  16. Chemotherapy versus best supportive care for extensive small cell lung cancer. PMID: 14583943 [NOT CITED] [OLD Version]
  17. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer. PMID: 25400254 [NOT CITED] [LATEST Version]
  18. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer. PMID: 23949842 [NOT CITED] [LATEST Version]
  19. Concurrent chemoradiotherapy in non-small cell lung cancer. PMID: 20556756 [CITED] [LATEST Version]
  20. Concurrent chemoradiotherapy in non-small cell lung cancer. PMID: 15495029 [NOT CITED] [OLD Version]
  21. Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. PMID: 11034766 [NOT CITED] [LATEST Version]
  22. Drugs for preventing lung cancer in healthy people. PMID: 23076895 [NOT CITED] [LATEST Version]
  23. Drugs for preventing lung cancer in healthy people. PMID: 12804424 [NOT CITED] [OLD Version]
  24. Early versus late chest radiotherapy for limited stage small cell lung cancer. PMID: 15674960 [CITED] [LATEST Version]
  25. Elemene for the treatment of lung cancer. PMID: 17943880 [NOT CITED] [LATEST Version]
  26. Exercise training for advanced lung cancer. PMID: 30741408 [CITED] [LATEST Version]
  27. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. PMID: 31204439 [CITED] [LATEST Version]
  28. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. PMID: 23904353 [NOT CITED] [OLD Version]
  29. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. PMID: 27223332 [CITED] [LATEST Version]
  30. Gefitinib for advanced non-small cell lung cancer. PMID: 29336009 [NOT CITED] [LATEST Version]
  31. Green tea (Camellia sinensis) for the prevention of cancer. PMID: 19588362 [NOT CITED] [LATEST Version]
  32. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent. PMID: 29247502 [NOT CITED] [LATEST Version]
  33. Intermittent versus continuous androgen suppression for prostatic cancer. PMID: 17943832 [NOT CITED] [LATEST Version]
  34. Interventions for cough in cancer. PMID: 25989380 [NOT CITED] [LATEST Version]
  35. Interventions for cough in cancer. PMID: 20824870 [NOT CITED] [OLD Version]
  36. Interventions for fatigue and weight loss in adults with advanced progressive illness. PMID: 22258985 [NOT CITED] [LATEST Version]
  37. Interventions for promoting habitual exercise in people living with and beyond cancer. PMID: 30229557 [NOT CITED] [LATEST Version]
  38. Interventions for smoking cessation in people diagnosed with lung cancer. PMID: 31173336 [CITED] [LATEST Version]
  39. Interventions for smoking cessation in people diagnosed with lung cancer. PMID: 26632766 [NOT CITED] [OLD Version]
  40. Long term hormone therapy for perimenopausal and postmenopausal women. PMID: 22786488 [NOT CITED] [LATEST Version]
  41. Long-term hormone therapy for perimenopausal and postmenopausal women. PMID: 28093732 [NOT CITED] [LATEST Version]
  42. Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer). PMID: 30001476 [NOT CITED] [LATEST Version]
  43. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. PMID: 21901689 [CITED] [LATEST Version]
  44. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. PMID: 15495096 [NOT CITED] [OLD Version]
  45. Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients. PMID: 30840317 [NOT CITED] [LATEST Version]
  46. Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients. PMID: 26407182 [NOT CITED] [OLD Version]
  47. Oral anticoagulation for prolonging survival in patients with cancer. PMID: 17443622 [NOT CITED] [LATEST Version]
  48. Palliative endobronchial brachytherapy for non-small cell lung cancer. PMID: 23235606 [CITED] [LATEST Version]
  49. Palliative endobronchial brachytherapy for non-small cell lung cancer. PMID: 18425900 [NOT CITED] [OLD Version]
  50. Palliative radiotherapy regimens for non-small cell lung cancer. PMID: 17054152 [NOT CITED] [LATEST Version]
  51. Palliative radiotherapy regimens for non-small cell lung cancer. PMID: 11687016 [NOT CITED] [OLD Version]
  52. Palliative radiotherapy regimens for non-small cell lung cancer. PMID: 11406035 [NOT CITED] [OLD Version]
  53. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer. PMID: 25586198 [CITED] [LATEST Version]
  54. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. PMID: 17636846 [NOT CITED] [LATEST Version]
  55. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. PMID: 25393718 [CITED] [LATEST Version]
  56. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. PMID: 26233609 [CITED] [LATEST Version]
  57. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. PMID: 18843733 [NOT CITED] [OLD Version]
  58. Postoperative radiotherapy for non-small cell lung cancer. PMID: 27727451 [NOT CITED] [LATEST Version]
  59. Postoperative radiotherapy for non-small cell lung cancer. PMID: 27684386 [NOT CITED] [OLD Version]
  60. Postoperative radiotherapy for non-small cell lung cancer. PMID: 15846628 [CITED] [OLD Version] [UPDATE NEEDED]
  61. Postoperative radiotherapy for non-small cell lung cancer. PMID: 12535431 [NOT CITED] [OLD Version]
  62. Postoperative radiotherapy for non-small cell lung cancer. PMID: 10796868 [NOT CITED] [OLD Version]
  63. Preoperative exercise training for patients with non-small cell lung cancer. PMID: 28589547 [NOT CITED] [LATEST Version]
  64. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. PMID: 26687844 [NOT CITED] [LATEST Version]
  65. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer. PMID: 15846743 [CITED] [LATEST Version]
  66. Radical multimodality therapy for malignant pleural mesothelioma. PMID: 29309720 [NOT CITED] [LATEST Version]
  67. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). PMID: 11279780 [NOT CITED] [OLD Version]
  68. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). PMID: 11406051 [NOT CITED] [LATEST Version]
  69. Screening for colorectal cancer using the faecal occult blood test, hemoccult. PMID: 10796760 [NOT CITED] [LATEST Version]
  70. Screening for lung cancer. PMID: 23794187 [CITED] [LATEST Version]
  71. Screening for lung cancer. PMID: 14973979 [NOT CITED] [OLD Version]
  72. Screening for lung cancer. PMID: 11687005 [NOT CITED] [OLD Version]
  73. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease. PMID: 17943820 [NOT CITED] [LATEST Version]
  74. Second-line chemotherapy for non-small cell lung cancer. PMID: 12076452 [NOT CITED] [LATEST Version]
  75. Second-line chemotherapy for non-small cell lung cancer. PMID: 11687161 [NOT CITED] [OLD Version]
  76. Selenium for preventing cancer. PMID: 29376219 [NOT CITED] [LATEST Version]
  77. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. PMID: 11687105 [NOT CITED] [LATEST Version]
  78. Surgery for early stage non-small cell lung cancer. PMID: 15674959 [CITED] [LATEST Version]
  79. Surgery for limited-stage small-cell lung cancer. PMID: 28429473 [NOT CITED] [LATEST Version]
  80. Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. PMID: 16437498 [NOT CITED] [LATEST Version]
  81. Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer. PMID: 20091536 [NOT CITED] [LATEST Version]
  82. Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer. PMID: 16034884 [NOT CITED] [OLD Version]
  83. Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer. PMID: 11687173 [NOT CITED] [OLD Version]
  84. Treatment for Lambert-Eaton myasthenic syndrome. PMID: 21328260 [NOT CITED] [LATEST Version]
  85. Treatment for Lambert-Eaton myasthenic syndrome. PMID: 15846654 [NOT CITED] [OLD Version]
  86. Treatment for Lambert-Eaton myasthenic syndrome. PMID: 12804456 [NOT CITED] [OLD Version]
  87. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. PMID: 29365347 [NOT CITED] [LATEST Version]
3475 Q836356 croup Croup GA 1-Top

Pulmonology
  1. Antibiotics for preventing complications in children with measles. PMID: 23943263 [NOT CITED] [LATEST Version]
  2. Antibiotics for preventing complications in children with measles. PMID: 18646073 [NOT CITED] [OLD Version]
  3. Glucocorticoids for croup in children. PMID: 30133690 [CITED] [LATEST Version]
  4. Glucocorticoids for croup. PMID: 21249651 [CITED] [LATEST Version]
  5. Glucocorticoids for croup. PMID: 14973975 [NOT CITED] [OLD Version]
  6. Glucocorticoids for croup. PMID: 10796674 [NOT CITED] [OLD Version]
  7. Heliox for croup in children. PMID: 30371952 [CITED] [LATEST Version]
  8. Heliox for croup in children. PMID: 24318607 [NOT CITED] [OLD Version]
  9. Heliox for croup in children. PMID: 20166089 [NOT CITED] [OLD Version]
  10. Humidified air inhalation for treating croup. PMID: 16855994 [NOT CITED] [LATEST Version]
  11. Interventions for managing asthma in pregnancy. PMID: 25331331 [NOT CITED] [LATEST Version]
  12. Nebulized epinephrine for croup in children. PMID: 24114291 [CITED] [LATEST Version]
  13. Nebulized epinephrine for croup in children. PMID: 21328284 [NOT CITED] [OLD Version]
  14. Nebulized racemic epinephrine for extubation of newborn infants. PMID: 11869578 [NOT CITED] [LATEST Version]
  15. Nebulized racemic epinephrine for extubation of newborn infants. PMID: 11279697 [NOT CITED] [OLD Version]
  16. Nebulized racemic epinephrine for extubation of newborn infants. PMID: 10796376 [NOT CITED] [OLD Version]
  17. Vitamin A for treating measles in children. PMID: 16235283 [NOT CITED] [LATEST Version]
  18. Vitamin A for treating measles in children. PMID: 11869601 [NOT CITED] [OLD Version]
  19. Vitamin A for treating measles in children. PMID: 11405993 [NOT CITED] [OLD Version]
4310 Q2840 influenza Influenza FA 1-Top

Pulmonology
  1. Amantadine and rimantadine for influenza A in adults. PMID: 16625539 [NOT CITED] [LATEST Version]
  2. Amantadine and rimantadine for influenza A in children and the elderly. PMID: 25415374 [NOT CITED] [LATEST Version]
  3. Amantadine and rimantadine for influenza A in children and the elderly. PMID: 22258950 [NOT CITED] [OLD Version]
  4. Amantadine and rimantadine for influenza A in children and the elderly. PMID: 18254006 [NOT CITED] [OLD Version]
  5. Amantadine and rimantadine for preventing and treating influenza A in adults. PMID: 15266442 [NOT CITED] [LATEST Version]
  6. Amantadine and rimantadine for preventing and treating influenza A in adults. PMID: 12137620 [NOT CITED] [OLD Version]
  7. Amantadine and rimantadine for preventing and treating influenza A in adults. PMID: 11405978 [NOT CITED] [OLD Version]
  8. Amantadine and rimantadine for preventing and treating influenza A in adults. PMID: 10796612 [NOT CITED] [OLD Version]
  9. Chinese medicinal herbs for influenza. PMID: 23543533 [NOT CITED] [LATEST Version]
  10. Chinese medicinal herbs for influenza. PMID: 17943819 [NOT CITED] [OLD Version]
  11. Chinese medicinal herbs for influenza. PMID: 15674953 [NOT CITED] [OLD Version]
  12. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). PMID: 19588375 [NOT CITED] [LATEST Version]
  13. Corticosteroids as adjunctive therapy in the treatment of influenza. PMID: 30798570 [CITED] [LATEST Version]
  14. Corticosteroids as adjunctive therapy in the treatment of influenza. PMID: 26950335 [NOT CITED] [OLD Version]
  15. Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults. PMID: 27545762 [CITED] [LATEST Version]
  16. Green and black tea for the primary prevention of cardiovascular disease. PMID: 23780706 [NOT CITED] [LATEST Version]
  17. Homeopathic Oscillococcinum(®) for preventing and treating influenza and influenza-like illness. PMID: 23235586 [NOT CITED] [LATEST Version]
  18. Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness. PMID: 25629583 [NOT CITED] [LATEST Version]
  19. Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. PMID: 16855981 [NOT CITED] [LATEST Version]
  20. Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. PMID: 14973976 [NOT CITED] [OLD Version]
  21. Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. PMID: 10796675 [NOT CITED] [OLD Version]
  22. Humidified air inhalation for treating croup. PMID: 16855994 [NOT CITED] [LATEST Version]
  23. Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. PMID: 26059051 [NOT CITED] [LATEST Version]
  24. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. PMID: 27251461 [CITED] [LATEST Version]
  25. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. PMID: 23881655 [NOT CITED] [OLD Version]
  26. Influenza vaccination for healthcare workers who work with the elderly. PMID: 20166073 [NOT CITED] [LATEST Version]
  27. Influenza vaccination for healthcare workers who work with the elderly. PMID: 16856082 [NOT CITED] [OLD Version]
  28. Influenza vaccination in children being treated with chemotherapy for cancer. PMID: 23904194 [NOT CITED] [LATEST Version]
  29. Influenza vaccination in children being treated with chemotherapy for cancer. PMID: 19370636 [NOT CITED] [OLD Version]
  30. Influenza vaccine for children and adults with bronchiectasis. PMID: 17636836 [NOT CITED] [LATEST Version]
  31. Influenza vaccine for chronic obstructive pulmonary disease (COPD). PMID: 29943802 [CITED] [LATEST Version]
  32. Influenza vaccine for patients with chronic obstructive pulmonary disease. PMID: 16437444 [NOT CITED] [LATEST Version]
  33. Influenza vaccine for patients with chronic obstructive pulmonary disease. PMID: 11034751 [NOT CITED] [OLD Version]
  34. Influenza vaccines for preventing acute otitis media in infants and children. PMID: 29039160 [NOT CITED] [LATEST Version]
  35. Influenza vaccines for preventing acute otitis media in infants and children. PMID: 25803008 [NOT CITED] [OLD Version]
  36. Influenza vaccines for preventing cardiovascular disease. PMID: 25940444 [NOT CITED] [LATEST Version]
  37. Influenza vaccines for preventing coronary heart disease. PMID: 18646119 [NOT CITED] [LATEST Version]
  38. Influenza vaccines in immunosuppressed adults with cancer. PMID: 29388675 [NOT CITED] [LATEST Version]
  39. Influenza vaccines in immunosuppressed adults with cancer. PMID: 24166741 [NOT CITED] [OLD Version]
  40. Interventions aimed at improving immunization rates. PMID: 12519624 [NOT CITED] [LATEST Version]
  41. Interventions for the interruption or reduction of the spread of respiratory viruses. PMID: 17943895 [NOT CITED] [LATEST Version]
  42. Interventions to increase influenza vaccination rates of those 60 years and older in the community. PMID: 29845606 [NOT CITED] [LATEST Version]
  43. Interventions to increase influenza vaccination rates of those 60 years and older in the community. PMID: 24999919 [NOT CITED] [OLD Version]
  44. Interventions to increase influenza vaccination rates of those 60 years and older in the community. PMID: 20824843 [NOT CITED] [OLD Version]
  45. Mucolytics for bronchiectasis. PMID: 11279712 [NOT CITED] [LATEST Version]
  46. Mucolytics for bronchiectasis. PMID: 10796636 [NOT CITED] [OLD Version]
  47. Neuraminidase inhibitors for influenza: methods change, principles don't. PMID: 22336870 [NOT CITED] [LATEST Version]
  48. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). PMID: 22513907 [NOT CITED] [LATEST Version]
  49. Neuraminidase inhibitors for preventing and treating influenza in children. PMID: 22258949 [NOT CITED] [LATEST Version]
  50. Neuraminidase inhibitors for preventing and treating influenza in children. PMID: 17253479 [NOT CITED] [OLD Version]
  51. Neuraminidase inhibitors for preventing and treating influenza in children. PMID: 12917931 [NOT CITED] [OLD Version]
  52. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. PMID: 24718923 [NOT CITED] [LATEST Version]
  53. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. PMID: 22258996 [NOT CITED] [OLD Version]
  54. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. PMID: 20166059 [NOT CITED] [LATEST Version]
  55. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. PMID: 16855962 [NOT CITED] [OLD Version]
  56. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. PMID: 10796625 [NOT CITED] [OLD Version]
  57. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. PMID: 26905631 [NOT CITED] [LATEST Version]
  58. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. PMID: 24515341 [NOT CITED] [OLD Version]
  59. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. PMID: 20238363 [NOT CITED] [OLD Version]
  60. Patient reminder and patient recall systems to improve immunization rates. PMID: 16034918 [NOT CITED] [LATEST Version]
  61. Patient reminder and recall interventions to improve immunization rates. PMID: 29342498 [NOT CITED] [LATEST Version]
  62. Physical interventions to interrupt or reduce the spread of respiratory viruses. PMID: 21735402 [CITED] [LATEST Version]
  63. Physical interventions to interrupt or reduce the spread of respiratory viruses. PMID: 20091588 [NOT CITED] [OLD Version]
  64. Pneumococcal conjugate vaccines for preventing acute otitis media in children. PMID: 31135969 [NOT CITED] [LATEST Version]
  65. Pneumococcal conjugate vaccines for preventing otitis media. PMID: 24696098 [NOT CITED] [LATEST Version]
  66. Pneumococcal vaccines for children and adults with bronchiectasis. PMID: 19370631 [NOT CITED] [LATEST Version]
  67. Probiotics for maintenance of remission in ulcerative colitis. PMID: 22161412 [NOT CITED] [LATEST Version]
  68. Teriflunomide for multiple sclerosis. PMID: 23235682 [NOT CITED] [LATEST Version]
  69. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. PMID: 27314455 [NOT CITED] [LATEST Version]
  70. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. PMID: 24282073 [NOT CITED] [OLD Version]
  71. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. PMID: 23076917 [NOT CITED] [OLD Version]
  72. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. PMID: 17443603 [NOT CITED] [OLD Version]
  73. Vaccines for preventing influenza in healthy adults. PMID: 29388196 [CITED] [LATEST Version]
  74. Vaccines for preventing influenza in healthy adults. PMID: 24623315 [NOT CITED] [OLD Version]
  75. Vaccines for preventing influenza in healthy adults. PMID: 20614424 [NOT CITED] [OLD Version]
  76. Vaccines for preventing influenza in healthy adults. PMID: 17443504 [NOT CITED] [OLD Version]
  77. Vaccines for preventing influenza in healthy adults. PMID: 15266445 [NOT CITED] [OLD Version]
  78. Vaccines for preventing influenza in healthy adults. PMID: 11687102 [NOT CITED] [OLD Version]
  79. Vaccines for preventing influenza in healthy adults. PMID: 10796628 [NOT CITED] [OLD Version]
  80. Vaccines for preventing influenza in healthy children. PMID: 29388195 [CITED] [LATEST Version]
  81. Vaccines for preventing influenza in healthy children. PMID: 22895945 [NOT CITED] [OLD Version]
  82. Vaccines for preventing influenza in healthy children. PMID: 18425905 [NOT CITED] [OLD Version]
  83. Vaccines for preventing influenza in healthy children. PMID: 16437500 [NOT CITED] [OLD Version]
  84. Vaccines for preventing influenza in people with asthma (Cochrane Review). PMID: 11034684 [NOT CITED] [LATEST Version]
  85. Vaccines for preventing influenza in people with asthma. PMID: 23450529 [CITED] [LATEST Version]
  86. Vaccines for preventing influenza in people with asthma. PMID: 18425863 [NOT CITED] [OLD Version]
  87. Vaccines for preventing influenza in people with asthma. PMID: 15106150 [NOT CITED] [OLD Version]
  88. Vaccines for preventing influenza in people with asthma. PMID: 10796536 [NOT CITED] [OLD Version]
  89. Vaccines for preventing influenza in people with cystic fibrosis. PMID: 24604671 [NOT CITED] [LATEST Version]
  90. Vaccines for preventing influenza in people with cystic fibrosis. PMID: 19821281 [NOT CITED] [OLD Version]
  91. Vaccines for preventing influenza in people with cystic fibrosis. PMID: 10796814 [NOT CITED] [OLD Version]
  92. Vaccines for preventing influenza in the elderly. PMID: 29388197 [NOT CITED] [LATEST Version]
  93. Vaccines for preventing influenza in the elderly. PMID: 20166072 [NOT CITED] [OLD Version]
  94. Vaccines for preventing influenza in the elderly. PMID: 16856068 [NOT CITED] [OLD Version]
  95. Vaccines for prophylaxis of viral infections in patients with hematological malignancies. PMID: 21412895 [NOT CITED] [LATEST Version]
  96. Vaccines for women for preventing neonatal tetanus. PMID: 26144877 [NOT CITED] [LATEST Version]
  97. Vaccines for women to prevent neonatal tetanus. PMID: 23728640 [NOT CITED] [LATEST Version]
4562 Q35869 asthma Asthma GA 1-Top

Pulmonology
  1. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. PMID: 28301050 [CITED] [LATEST Version]
  2. Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. PMID: 15106191 [CITED] [LATEST Version]
  3. Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma. PMID: 24089325 [CITED] [LATEST Version]
  4. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. PMID: 19821344 [CITED] [LATEST Version]
  5. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. PMID: 15846751 [NOT CITED] [LATEST Version]
  6. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. PMID: 23235591 [CITED] [LATEST Version]
  7. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. PMID: 23235685 [CITED] [LATEST Version]
  8. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. PMID: 19588447 [NOT CITED] [LATEST Version]
  9. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. PMID: 26594816 [CITED] [LATEST Version]
  10. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. PMID: 20464739 [CITED] [LATEST Version]
  11. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. PMID: 20393943 [CITED] [LATEST Version]
  12. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. PMID: 24459050 [CITED] [LATEST Version]
  13. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. PMID: 21563136 [NOT CITED] [OLD Version]
  14. Alexander technique for chronic asthma. PMID: 22972048 [NOT CITED] [LATEST Version]
  15. Anti-IgE for chronic asthma in adults and children. PMID: 16625585 [NOT CITED] [LATEST Version]
  16. Anti-IgE for chronic asthma in adults and children. PMID: 15266491 [NOT CITED] [OLD Version]
  17. Anti-IL5 therapies for asthma. PMID: 28933516 [NOT CITED] [LATEST Version]
  18. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. PMID: 22592685 [NOT CITED] [LATEST Version]
  19. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. PMID: 15106175 [NOT CITED] [OLD Version]
  20. Antibiotics for exacerbations of asthma. PMID: 29938789 [CITED] [LATEST Version]
  21. Anticholinergic agents for chronic asthma in adults. PMID: 15266477 [CITED] [LATEST Version]
  22. Anticholinergic therapy for acute asthma in children. PMID: 22513916 [CITED] [LATEST Version]
  23. Asthma challenges: The place of inhaled long-acting beta-agonists. PMID: 21833925 [NOT CITED] [LATEST Version]
  24. Asthma education for school staff. PMID: 28402017 [CITED] [LATEST Version]
  25. Azathioprine as an oral corticosteroid sparing agent for asthma. PMID: 14974011 [NOT CITED] [LATEST Version]
  26. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. PMID: 15266440 [NOT CITED] [LATEST Version]
  27. Beta₂-agonists for exercise-induced asthma. PMID: 24089311 [NOT CITED] [LATEST Version]
  28. Breathing exercises for adults with asthma. PMID: 24085551 [NOT CITED] [LATEST Version]
  29. Breathing exercises for children with asthma. PMID: 27070225 [CITED] [LATEST Version]
  30. Bronchial thermoplasty for moderate or severe persistent asthma in adults. PMID: 24585221 [NOT CITED] [LATEST Version]
  31. Caffeine for asthma. PMID: 20091514 [CITED] [LATEST Version]
  32. Calorie controlled diet for chronic asthma. PMID: 16034941 [NOT CITED] [LATEST Version]
  33. Chronic disease management programmes for adults with asthma. PMID: 26014500 [NOT CITED] [LATEST Version]
  34. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children. PMID: 23450613 [NOT CITED] [LATEST Version]
  35. Ciclesonide versus other inhaled steroids for chronic asthma in children and adults. PMID: 18425977 [NOT CITED] [LATEST Version]
  36. Ciclesonide versus placebo for chronic asthma in adults and children. PMID: 18425941 [NOT CITED] [LATEST Version]
  37. Cognitive behavioural therapy (CBT) for adults and adolescents with asthma. PMID: 27649894 [CITED] [LATEST Version]
  38. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. PMID: 22161385 [NOT CITED] [LATEST Version]
  39. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. PMID: 18646100 [NOT CITED] [OLD Version]
  40. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. PMID: 24343671 [NOT CITED] [LATEST Version]
  41. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. PMID: 23633340 [NOT CITED] [LATEST Version]
  42. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. PMID: 19370682 [NOT CITED] [LATEST Version]
  43. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. PMID: 19160317 [NOT CITED] [LATEST Version]
  44. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. PMID: 16235409 [NOT CITED] [LATEST Version]
  45. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. PMID: 23966133 [CITED] [LATEST Version]
  46. Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma. PMID: 28076656 [CITED] [LATEST Version]
  47. Corticosteroids for preventing relapse following acute exacerbations of asthma. PMID: 17636617 [NOT CITED] [LATEST Version]
  48. Culture-specific programs for children and adults from minority groups who have asthma. PMID: 28828760 [NOT CITED] [LATEST Version]
  49. Culture-specific programs for children and adults from minority groups who have asthma. PMID: 19370643 [NOT CITED] [OLD Version]
  50. Culture-specific programs for children and adults from minority groups who have asthma. PMID: 19160290 [NOT CITED] [OLD Version]
  51. Culture-specific programs for children and adults from minority groups who have asthma. PMID: 18425956 [NOT CITED] [OLD Version]
  52. Dehumidifiers for chronic asthma. PMID: 23760885 [CITED] [LATEST Version]
  53. Dietary salt reduction or exclusion for allergic asthma. PMID: 15266430 [NOT CITED] [LATEST Version]
  54. Dietary sodium manipulation and asthma. PMID: 21412865 [NOT CITED] [LATEST Version]
  55. Different oral corticosteroid regimens for acute asthma. PMID: 27176676 [NOT CITED] [LATEST Version]
  56. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. PMID: 23235589 [NOT CITED] [LATEST Version]
  57. Education interventions for adults who attend the emergency room for acute asthma. PMID: 17636712 [NOT CITED] [LATEST Version]
  58. Exhaled nitric oxide levels to guide treatment for adults with asthma. PMID: 27580628 [NOT CITED] [LATEST Version]
  59. Exhaled nitric oxide levels to guide treatment for children with asthma. PMID: 27825189 [NOT CITED] [LATEST Version]
  60. Family therapy for chronic asthma in children. PMID: 15846599 [CITED] [LATEST Version]
  61. Fluticasone at different doses for chronic asthma in adults and children. PMID: 18843646 [NOT CITED] [LATEST Version]
  62. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. PMID: 17943772 [NOT CITED] [LATEST Version]
  63. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children. PMID: 16625634 [NOT CITED] [LATEST Version]
  64. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children. PMID: 16235400 [NOT CITED] [OLD Version]
  65. Fluticasone versus placebo for chronic asthma in adults and children. PMID: 18843640 [NOT CITED] [LATEST Version]
  66. Fluticasone versus placebo for chronic asthma in adults and children. PMID: 16235315 [NOT CITED] [OLD Version]
  67. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. PMID: 20824877 [NOT CITED] [LATEST Version]
  68. Heliox for nonintubated acute asthma patients. PMID: 17054154 [NOT CITED] [LATEST Version]
  69. Herbal interventions for chronic asthma in adults and children. PMID: 18254089 [NOT CITED] [LATEST Version]
  70. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. PMID: 15106238 [NOT CITED] [LATEST Version]
  71. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. PMID: 24037768 [NOT CITED] [LATEST Version]
  72. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. PMID: 16625527 [NOT CITED] [OLD Version]
  73. Holding chambers versus nebulisers for inhaled steroids in chronic asthma. PMID: 16437434 [NOT CITED] [LATEST Version]
  74. Home telemonitoring and remote feedback between clinic visits for asthma. PMID: 27486836 [NOT CITED] [LATEST Version]
  75. Home-based educational interventions for children with asthma. PMID: 21975783 [CITED] [LATEST Version]
  76. House dust mite control measures for asthma. PMID: 18425868 [CITED] [LATEST Version]
  77. House dust mite control measures for asthma. PMID: 15495009 [NOT CITED] [OLD Version]
  78. How should we describe worsening asthma in Cochrane reviews, and does it matter? PMID: 25517002 [NOT CITED] [LATEST Version]
  79. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. PMID: 27272563 [NOT CITED] [LATEST Version]
  80. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. PMID: 21154378 [NOT CITED] [OLD Version]
  81. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. PMID: 20927759 [NOT CITED] [OLD Version]
  82. Indigenous healthcare worker involvement for Indigenous adults and children with asthma. PMID: 20464742 [NOT CITED] [LATEST Version]
  83. Indigenous healthcare worker involvement for Indigenous adults and children with asthma. PMID: 17943904 [NOT CITED] [OLD Version]
  84. Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. PMID: 25080126 [CITED] [LATEST Version]
  85. Inhaled beclomethasone versus placebo for chronic asthma. PMID: 15674896 [NOT CITED] [LATEST Version]
  86. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth. PMID: 25030199 [NOT CITED] [LATEST Version]
  87. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth. PMID: 31194879 [NOT CITED] [LATEST Version]
  88. Inhaled corticosteroids in children with persistent asthma: effects on growth. PMID: 25030198 [NOT CITED] [LATEST Version]
  89. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. PMID: 16625584 [NOT CITED] [LATEST Version]
  90. Inhaled fluticasone at different doses for chronic asthma in adults and children. PMID: 16034902 [NOT CITED] [LATEST Version]
  91. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children. PMID: 15846637 [NOT CITED] [LATEST Version]
  92. Inhaled fluticasone versus placebo for chronic asthma in adults and children. PMID: 15846649 [NOT CITED] [LATEST Version]
  93. Inhaled magnesium sulfate in the treatment of acute asthma. PMID: 29182799 [CITED] [LATEST Version]
  94. Inhaled magnesium sulfate in the treatment of acute asthma. PMID: 23235599 [NOT CITED] [OLD Version]
  95. Inhaled magnesium sulfate in the treatment of acute asthma. PMID: 16235345 [NOT CITED] [OLD Version]
  96. Inhaled magnesium sulfate in the treatment of acute asthma. PMID: 16034914 [NOT CITED] [OLD Version]
  97. Inhaled magnesium sulfate in the treatment of acute asthma. PMID: 15846687 [NOT CITED] [OLD Version]
  98. Inhaled sodium cromoglycate for asthma in children. PMID: 18843630 [NOT CITED] [LATEST Version]
  99. Inhaled steroids for acute asthma following emergency department discharge. PMID: 23235590 [NOT CITED] [LATEST Version]
  100. Inhaled steroids with and without regular formoterol for asthma: serious adverse events. PMID: 31553802 [NOT CITED] [LATEST Version]
  101. Inhaled steroids with and without regular salmeterol for asthma: serious adverse events. PMID: 30521673 [NOT CITED] [LATEST Version]
  102. Injection allergen immunotherapy for asthma. PMID: 20687065 [NOT CITED] [LATEST Version]
  103. Inspiratory muscle training for asthma. PMID: 24014205 [NOT CITED] [LATEST Version]
  104. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults. PMID: 26197430 [NOT CITED] [LATEST Version]
  105. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. PMID: 23450606 [NOT CITED] [LATEST Version]
  106. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. PMID: 23235678 [NOT CITED] [OLD Version]
  107. Interventions for autumn exacerbations of asthma in children. PMID: 29518252 [NOT CITED] [LATEST Version]
  108. Interventions for educating children who are at risk of asthma-related emergency department attendance. PMID: 19370563 [NOT CITED] [LATEST Version]
  109. Interventions for managing asthma in pregnancy. PMID: 25331331 [NOT CITED] [LATEST Version]
  110. Interventions to improve adherence to inhaled steroids for asthma. PMID: 28417456 [NOT CITED] [LATEST Version]
  111. Interventions to improve inhaler technique for people with asthma. PMID: 28288272 [NOT CITED] [LATEST Version]
  112. Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma. PMID: 29859017 [NOT CITED] [LATEST Version]
  113. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. PMID: 15846615 [NOT CITED] [LATEST Version]
  114. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. PMID: 23235686 [NOT CITED] [LATEST Version]
  115. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. PMID: 24865567 [CITED] [LATEST Version]
  116. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. PMID: 27126744 [CITED] [LATEST Version]
  117. Ionisers for chronic asthma. PMID: 22972060 [CITED] [LATEST Version]
  118. Ketamine for management of acute exacerbations of asthma in children. PMID: 23152273 [NOT CITED] [LATEST Version]
  119. Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children. PMID: 14973969 [NOT CITED] [LATEST Version]
  120. Lay-led and peer support interventions for adolescents with asthma. PMID: 28421600 [NOT CITED] [LATEST Version]
  121. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. PMID: 22592708 [CITED] [LATEST Version]
  122. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children. PMID: 16235393 [NOT CITED] [LATEST Version]
  123. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. PMID: 17253458 [NOT CITED] [LATEST Version]
  124. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. PMID: 17054161 [NOT CITED] [LATEST Version]
  125. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. PMID: 15674901 [NOT CITED] [OLD Version]
  126. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. PMID: 16235410 [NOT CITED] [LATEST Version]
  127. Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma. PMID: 17636663 [NOT CITED] [LATEST Version]
  128. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. PMID: 26798035 [NOT CITED] [LATEST Version]
  129. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma. PMID: 26031392 [NOT CITED] [LATEST Version]
  130. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma. PMID: 26196545 [NOT CITED] [LATEST Version]
  131. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. PMID: 26301488 [NOT CITED] [LATEST Version]
  132. Macrolides for chronic asthma. PMID: 26371536 [NOT CITED] [LATEST Version]
  133. Macrolides for chronic asthma. PMID: 16235309 [NOT CITED] [OLD Version]
  134. Macrolides for chronic asthma. PMID: 16034882 [NOT CITED] [OLD Version]
  135. Manual therapy for asthma. PMID: 15846609 [CITED] [LATEST Version]
  136. Mepolizumab versus placebo for asthma. PMID: 26214266 [NOT CITED] [LATEST Version]
  137. Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma. PMID: 19588394 [NOT CITED] [LATEST Version]
  138. Monosodium glutamate avoidance for chronic asthma in adults and children. PMID: 22696342 [NOT CITED] [LATEST Version]
  139. Nedocromil sodium for chronic asthma in children. PMID: 16856028 [NOT CITED] [LATEST Version]
  140. Non-invasive positive pressure ventilation for acute asthma in children. PMID: 27687114 [CITED] [LATEST Version]
  141. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. PMID: 23235608 [NOT CITED] [LATEST Version]
  142. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. PMID: 16034928 [NOT CITED] [OLD Version]
  143. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. PMID: 15674944 [NOT CITED] [OLD Version]
  144. Nurse versus physician-led care for the management of asthma. PMID: 23450599 [NOT CITED] [LATEST Version]
  145. Omalizumab for asthma in adults and children. PMID: 24414989 [NOT CITED] [LATEST Version]
  146. Oral xanthines as maintenance treatment for asthma in children. PMID: 16437447 [NOT CITED] [LATEST Version]
  147. Patient- and parent-initiated oral steroids for asthma exacerbations. PMID: 27943237 [NOT CITED] [LATEST Version]
  148. Personalised asthma action plans for adults with asthma. PMID: 28394084 [NOT CITED] [LATEST Version]
  149. Physical training for asthma. PMID: 24085631 [CITED] [LATEST Version]
  150. Physical training for asthma. PMID: 22592674 [NOT CITED] [OLD Version]
  151. Physical training for asthma. PMID: 16235280 [NOT CITED] [OLD Version]
  152. Primary care based clinics for asthma. PMID: 22513914 [NOT CITED] [LATEST Version]
  153. Psychological interventions for adults with asthma. PMID: 16437449 [NOT CITED] [LATEST Version]
  154. Psychological interventions for children with asthma. PMID: 16235317 [NOT CITED] [LATEST Version]
  155. Pulse oximeters to self monitor oxygen saturation levels as part of a personalised asthma action plan for people with asthma. PMID: 26410043 [NOT CITED] [LATEST Version]
  156. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. PMID: 20091646 [NOT CITED] [LATEST Version]
  157. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. PMID: 23744625 [NOT CITED] [LATEST Version]
  158. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. PMID: 19370661 [NOT CITED] [OLD Version]
  159. Regular treatment with formoterol for chronic asthma: serious adverse events. PMID: 22513944 [CITED] [LATEST Version]
  160. Regular treatment with formoterol for chronic asthma: serious adverse events. PMID: 18843738 [NOT CITED] [OLD Version]
  161. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. PMID: 22419326 [NOT CITED] [LATEST Version]
  162. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. PMID: 19821436 [NOT CITED] [OLD Version]
  163. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. PMID: 23543548 [NOT CITED] [LATEST Version]
  164. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. PMID: 19588410 [NOT CITED] [OLD Version]
  165. Regular treatment with salmeterol for chronic asthma: serious adverse events. PMID: 18646149 [CITED] [LATEST Version]
  166. Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma. PMID: 25715323 [NOT CITED] [LATEST Version]
  167. Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma. PMID: 21901714 [NOT CITED] [OLD Version]
  168. Remote versus face-to-face check-ups for asthma. PMID: 27087257 [NOT CITED] [LATEST Version]
  169. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews. PMID: 24504983 [NOT CITED] [LATEST Version]
  170. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews. PMID: 23076961 [NOT CITED] [LATEST Version]
  171. School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review. PMID: 30687940 [NOT CITED] [LATEST Version]
  172. Selenium supplementation for asthma. PMID: 15106206 [NOT CITED] [LATEST Version]
  173. Shared decision-making for people with asthma. PMID: 28972652 [CITED] [LATEST Version]
  174. Smartphone and tablet self management apps for asthma. PMID: 24282112 [NOT CITED] [LATEST Version]
  175. Stepping down the dose of inhaled corticosteroids for adults with asthma. PMID: 28146601 [NOT CITED] [LATEST Version]
  176. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. PMID: 26089258 [CITED] [LATEST Version]
  177. Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids. PMID: 25997166 [CITED] [LATEST Version]
  178. Sublingual immunotherapy for asthma. PMID: 26315994 [NOT CITED] [LATEST Version]
  179. Swimming training for asthma in children and adolescents aged 18 years and under. PMID: 23633375 [NOT CITED] [LATEST Version]
  180. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. PMID: 19821360 [NOT CITED] [LATEST Version]
  181. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. PMID: 18425949 [NOT CITED] [OLD Version]
  182. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. PMID: 28837221 [NOT CITED] [LATEST Version]
  183. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. PMID: 17443604 [NOT CITED] [OLD Version]
  184. Tailoring asthma therapies using FeNO: can a new objective measure help more people to gain control and reduce over-treatment? PMID: 27616040 [NOT CITED] [LATEST Version]
  185. Telehealthcare for asthma. PMID: 20927763 [NOT CITED] [LATEST Version]
  186. Vaccines for preventing influenza in people with asthma. PMID: 23450529 [CITED] [LATEST Version]
  187. Vaccines for preventing influenza in people with asthma. PMID: 18425863 [NOT CITED] [OLD Version]
  188. Vaccines for preventing influenza in people with asthma. PMID: 15106150 [NOT CITED] [OLD Version]
  189. Vilanterol and fluticasone furoate for asthma. PMID: 27582089 [NOT CITED] [LATEST Version]
  190. Vitamin C for asthma and exercise-induced bronchoconstriction. PMID: 24154977 [CITED] [LATEST Version]
  191. Vitamin C supplementation for asthma. PMID: 19160185 [NOT CITED] [LATEST Version]
  192. Vitamin C supplementation for asthma. PMID: 15266435 [NOT CITED] [OLD Version]
  193. Vitamin D for the management of asthma. PMID: 27595415 [CITED] [LATEST Version]
  194. Vitamins C and E for asthma and exercise-induced bronchoconstriction. PMID: 24936673 [CITED] [LATEST Version]
  195. Water-based exercise for adults with asthma. PMID: 25032820 [NOT CITED] [LATEST Version]
  196. Weight loss interventions for chronic asthma. PMID: 22786526 [CITED] [LATEST Version]
  197. Workplace interventions for treatment of occupational asthma. PMID: 21563151 [NOT CITED] [LATEST Version]
  198. Written action plans for asthma in children. PMID: 16856090 [CITED] [LATEST Version]
  199. Written emotional disclosure for asthma. PMID: 24842151 [CITED] [LATEST Version]
  200. Yoga for asthma. PMID: 27115477 [CITED] [LATEST Version]
4486 Q12204 tuberculosis Tuberculosis GA 1-Top

Dermatology

Pulmonology
  1. Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive individuals. PMID: 31565799 [NOT CITED] [LATEST Version]
  2. Active case finding in contacts of people with tuberculosis. PMID: 21901723 [NOT CITED] [LATEST Version]
  3. Acupuncture for chronic hepatitis B. PMID: 31436846 [NOT CITED] [LATEST Version]
  4. Adjunctive steroid therapy for managing pulmonary tuberculosis. PMID: 25387839 [NOT CITED] [LATEST Version]
  5. Adverse effects of biologics: a network meta-analysis and Cochrane overview. PMID: 21328309 [NOT CITED] [LATEST Version]
  6. Anti-TNF agents for paediatric psoriasis. PMID: 26598969 [NOT CITED] [LATEST Version]
  7. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis. PMID: 24590589 [NOT CITED] [LATEST Version]
  8. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. PMID: 28000919 [NOT CITED] [LATEST Version]
  9. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. PMID: 25470304 [NOT CITED] [OLD Version]
  10. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. PMID: 23235684 [NOT CITED] [OLD Version]
  11. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under. PMID: 26408070 [NOT CITED] [LATEST Version]
  12. Antibiotics for treating scrub typhus. PMID: 30246875 [NOT CITED] [LATEST Version]
  13. Antifibrinolytic therapy to reduce haemoptysis from any cause. PMID: 27806184 [NOT CITED] [LATEST Version]
  14. Antifibrinolytic therapy to reduce haemoptysis from any cause. PMID: 22513965 [NOT CITED] [OLD Version]
  15. Carbamazepine for cocaine dependence. PMID: 12076433 [NOT CITED] [LATEST Version]
  16. Carbamazepine for cocaine dependence. PMID: 11687133 [NOT CITED] [OLD Version]
  17. Carbamazepine for cocaine dependence. PMID: 10796844 [NOT CITED] [OLD Version]
  18. Community-based supplementary feeding for food insecure, vulnerable and malnourished populations - an overview of systematic reviews. PMID: 30480324 [NOT CITED] [LATEST Version]
  19. Contact tracing strategies in household and congregate environments to identify cases of tuberculosis in low- and moderate-incidence populations. PMID: 31461540 [NOT CITED] [LATEST Version]
  20. Corticosteroids for managing tuberculous meningitis. PMID: 27121755 [NOT CITED] [LATEST Version]
  21. Corticosteroids for managing tuberculous meningitis. PMID: 18254003 [NOT CITED] [OLD Version]
  22. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. PMID: 12917946 [NOT CITED] [LATEST Version]
  23. Directly observed therapy for treating tuberculosis. PMID: 26022367 [CITED] [LATEST Version]
  24. Directly observed therapy for treating tuberculosis. PMID: 17943789 [NOT CITED] [OLD Version]
  25. Directly observed therapy for treating tuberculosis. PMID: 16625579 [NOT CITED] [OLD Version]
  26. Directly observed therapy for treating tuberculosis. PMID: 12535470 [NOT CITED] [OLD Version]
  27. Directly observed therapy for treating tuberculosis. PMID: 11687192 [NOT CITED] [OLD Version]
  28. Dopamine agonists for cocaine dependence. PMID: 12804461 [NOT CITED] [LATEST Version]
  29. Dopamine agonists for cocaine dependence. PMID: 11687193 [NOT CITED] [OLD Version]
  30. Drugs for preventing tuberculosis in HIV infected persons. PMID: 10796501 [NOT CITED] [OLD Version]
  31. Drugs for preventing tuberculosis in HIV infected persons. PMID: 11034676 [NOT CITED] [LATEST Version]
  32. Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis. PMID: 16625639 [NOT CITED] [LATEST Version]
  33. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. PMID: 27943261 [NOT CITED] [LATEST Version]
  34. Financial arrangements for health systems in low-income countries: an overview of systematic reviews. PMID: 28891235 [NOT CITED] [LATEST Version]
  35. Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis. PMID: 27186634 [NOT CITED] [LATEST Version]
  36. Fluoroquinolones for treating tuberculosis (presumed drug-sensitive). PMID: 23744519 [NOT CITED] [LATEST Version]
  37. Fluoroquinolones for treating tuberculosis. PMID: 18254061 [NOT CITED] [LATEST Version]
  38. Fluoroquinolones for treating tuberculosis. PMID: 16034951 [NOT CITED] [OLD Version]
  39. Fully intermittent dosing with drugs for treating tuberculosis in adults. PMID: 11687088 [NOT CITED] [LATEST Version]
  40. Fully intermittent dosing with drugs for tuberculosis. PMID: 11034692 [NOT CITED] [LATEST Version]
  41. Fully intermittent dosing with drugs for tuberculosis. PMID: 10796561 [NOT CITED] [OLD Version]
  42. GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs. PMID: 27605387 [NOT CITED] [LATEST Version]
  43. Golimumab for rheumatoid arthritis. PMID: 20091667 [NOT CITED] [LATEST Version]
  44. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. PMID: 19160285 [NOT CITED] [LATEST Version]
  45. Implementation strategies for health systems in low-income countries: an overview of systematic reviews. PMID: 28895659 [NOT CITED] [LATEST Version]
  46. Incentives and enablers to improve adherence in tuberculosis. PMID: 26333525 [NOT CITED] [LATEST Version]
  47. Intermittent versus daily therapy for treating tuberculosis in children. PMID: 24470141 [NOT CITED] [LATEST Version]
  48. Interventions for promoting adherence to tuberculosis management. PMID: 11034666 [NOT CITED] [LATEST Version]
  49. Interventions for promoting adherence to tuberculosis management. PMID: 10796467 [NOT CITED] [OLD Version]
  50. Interventions for treating tuberculous pericarditis. PMID: 28902412 [NOT CITED] [LATEST Version]
  51. Interventions for treating tuberculous pericarditis. PMID: 12519546 [NOT CITED] [OLD Version]
  52. Interventions to increase tuberculosis case detection at primary healthcare or community-level services. PMID: 29182800 [NOT CITED] [LATEST Version]
  53. Isoniazid for preventing tuberculosis in HIV-infected children. PMID: 28850172 [NOT CITED] [LATEST Version]
  54. Isoniazid for preventing tuberculosis in non-HIV infected persons. PMID: 10796642 [NOT CITED] [LATEST Version]
  55. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. PMID: 27163343 [NOT CITED] [LATEST Version]
  56. Linezolid for drug-resistant pulmonary tuberculosis. PMID: 30893466 [NOT CITED] [LATEST Version]
  57. Low level laser therapy for treating tuberculosis. PMID: 16625582 [NOT CITED] [LATEST Version]
  58. Low level laser therapy for treating tuberculosis. PMID: 12137698 [NOT CITED] [OLD Version]
  59. Material incentives and enablers in the management of tuberculosis. PMID: 22258976 [NOT CITED] [LATEST Version]
  60. Micronutrient supplementation in adults with HIV infection. PMID: 28518221 [NOT CITED] [LATEST Version]
  61. MVA85A vaccine to enhance BCG for preventing tuberculosis. PMID: 31038197 [NOT CITED] [LATEST Version]
  62. Mycobacterium vaccae immunotherapy for treating tuberculosis. PMID: 12535403 [NOT CITED] [LATEST Version]
  63. Mycobacterium vaccae immunotherapy for treating tuberculosis. PMID: 11279709 [NOT CITED] [OLD Version]
  64. Mycobacterium vaccae immunotherapy for treating tuberculosis. PMID: 10796609 [NOT CITED] [OLD Version]
  65. Nutritional supplements for people being treated for active tuberculosis. PMID: 27355911 [NOT CITED] [LATEST Version]
  66. Nutritional supplements for people being treated for active tuberculosis. PMID: 22071828 [NOT CITED] [OLD Version]
  67. Nutritional supplements for people being treated for active tuberculosis. PMID: 18843702 [NOT CITED] [OLD Version]
  68. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old. PMID: 24114324 [NOT CITED] [LATEST Version]
  69. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. PMID: 20238364 [NOT CITED] [LATEST Version]
  70. Oxygen therapy for pneumonia in adults. PMID: 22419316 [NOT CITED] [LATEST Version]
  71. Patient education and counselling for promoting adherence to treatment for tuberculosis. PMID: 22592714 [NOT CITED] [LATEST Version]
  72. Paying for performance to improve the delivery of health interventions in low- and middle-income countries . PMID: 22336833 [NOT CITED] [LATEST Version]
  73. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. PMID: 25393718 [NOT CITED] [LATEST Version]
  74. Regimens of less than six months for treating tuberculosis. PMID: 10796641 [NOT CITED] [LATEST Version]
  75. Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. PMID: 18843723 [NOT CITED] [LATEST Version]
  76. Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment. PMID: 25403701 [CITED] [LATEST Version]
  77. Rifabutin for treating pulmonary tuberculosis. PMID: 17943842 [CITED] [LATEST Version]
  78. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. PMID: 23828580 [NOT CITED] [LATEST Version]
  79. Routine surgery in addition to chemotherapy for treating spinal tuberculosis. PMID: 16437489 [NOT CITED] [OLD Version]
  80. Routine surgery in addition to chemotherapy for treating spinal tuberculosis. PMID: 23866317 [NOT CITED] [LATEST Version]
  81. Six months therapy for tuberculous meningitis. PMID: 27581996 [NOT CITED] [LATEST Version]
  82. Six-month therapy for abdominal tuberculosis. PMID: 27801499 [NOT CITED] [LATEST Version]
  83. Smoking cessation interventions for pulmonary tuberculosis treatment outcomes. PMID: 26777994 [NOT CITED] [LATEST Version]
  84. Steroids for treating tuberculous pleurisy. PMID: 10796669 [NOT CITED] [LATEST Version]
  85. Strategies for integrating primary health services in low- and middle-income countries at the point of delivery. PMID: 21735392 [NOT CITED] [LATEST Version]
  86. Surgical versus non-surgical management of pleural empyema. PMID: 16235291 [NOT CITED] [LATEST Version]
  87. Surgical versus non-surgical management of pleural empyema. PMID: 12076430 [NOT CITED] [OLD Version]
  88. Symptom screening for active tuberculosis in pregnant women living with HIV. PMID: 29910691 [NOT CITED] [LATEST Version]
  89. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy. PMID: 24980859 [NOT CITED] [LATEST Version]
  90. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs. PMID: 25353401 [NOT CITED] [LATEST Version]
  91. TNF-alpha inhibitors for ankylosing spondylitis. PMID: 25887212 [NOT CITED] [LATEST Version]
  92. Treating BCG-induced disease in children. PMID: 23440826 [NOT CITED] [LATEST Version]
  93. Treatment of latent tuberculosis infection in HIV infected persons. PMID: 20091503 [NOT CITED] [LATEST Version]
  94. Treatment of latent tuberculosis infection in HIV infected persons. PMID: 14973947 [NOT CITED] [OLD Version]
  95. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. PMID: 14974022 [NOT CITED] [LATEST Version]
  96. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. PMID: 22336788 [NOT CITED] [LATEST Version]
  97. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. PMID: 12535469 [NOT CITED] [OLD Version]
  98. Vitamin D supplementation for preventing infections in children under five years of age. PMID: 27826955 [NOT CITED] [LATEST Version]
  99. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. PMID: 31173647 [NOT CITED] [LATEST Version]
  100. Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. PMID: 30148542 [NOT CITED] [LATEST Version]
  101. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. PMID: 24448973 [NOT CITED] [LATEST Version]
  102. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. PMID: 23440842 [NOT CITED] [OLD Version]
468 Q188605 pulmonary emphysema Pulmonary emphysema GA 1-Top

Pulmonology

 No matching publication found!
737 Q199804 chronic obstructive pulmonary disease Chronic obstructive pulmonary disease GA 1-Top

Pulmonology
  1. Aclidinium bromide for stable chronic obstructive pulmonary disease. PMID: 25234126 [CITED] [LATEST Version]
  2. Action plans for chronic obstructive pulmonary disease. PMID: 16235392 [NOT CITED] [LATEST Version]
  3. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease. PMID: 27990628 [CITED] [LATEST Version]
  4. Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. PMID: 20464737 [NOT CITED] [LATEST Version]
  5. Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease. PMID: 30306545 [NOT CITED] [LATEST Version]
  6. Airway clearance techniques for chronic obstructive pulmonary disease. PMID: 22419331 [CITED] [LATEST Version]
  7. Ambulatory oxygen for chronic obstructive pulmonary disease. PMID: 12076387 [NOT CITED] [LATEST Version]
  8. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. PMID: 24957353 [NOT CITED] [LATEST Version]
  9. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. PMID: 12519615 [NOT CITED] [LATEST Version]
  10. Antibiotics for exacerbations of chronic obstructive pulmonary disease. PMID: 30371937 [NOT CITED] [LATEST Version]
  11. Antibiotics for exacerbations of chronic obstructive pulmonary disease. PMID: 23235687 [NOT CITED] [OLD Version]
  12. Antibiotics for exacerbations of chronic obstructive pulmonary disease. PMID: 16625602 [NOT CITED] [OLD Version]
  13. Beclometasone for chronic obstructive pulmonary disease. PMID: 24105424 [NOT CITED] [LATEST Version]
  14. Breathing exercises for chronic obstructive pulmonary disease. PMID: 23076942 [CITED] [LATEST Version]
  15. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. PMID: 10796474 [NOT CITED] [LATEST Version]
  16. Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease. PMID: 28230230 [CITED] [LATEST Version]
  17. Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. PMID: 11279770 [NOT CITED] [LATEST Version]
  18. Cardioselective beta-blockers for chronic obstructive pulmonary disease. PMID: 16235327 [CITED] [LATEST Version]
  19. Cardioselective beta-blockers for chronic obstructive pulmonary disease. PMID: 12076486 [NOT CITED] [OLD Version]
  20. Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. PMID: 21412920 [NOT CITED] [LATEST Version]
  21. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. PMID: 23728670 [NOT CITED] [LATEST Version]
  22. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. PMID: 20464758 [NOT CITED] [OLD Version]
  23. Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. PMID: 27271056 [NOT CITED] [LATEST Version]
  24. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD). PMID: 30536566 [NOT CITED] [LATEST Version]
  25. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. PMID: 15266502 [NOT CITED] [LATEST Version]
  26. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. PMID: 23990350 [CITED] [LATEST Version]
  27. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. PMID: 22972099 [CITED] [LATEST Version]
  28. Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease. PMID: 17943917 [NOT CITED] [LATEST Version]
  29. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. PMID: 17943918 [NOT CITED] [LATEST Version]
  30. Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. PMID: 17943798 [NOT CITED] [LATEST Version]
  31. Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. PMID: 24214176 [NOT CITED] [LATEST Version]
  32. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. PMID: 14583994 [NOT CITED] [LATEST Version]
  33. Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease. PMID: 28535331 [NOT CITED] [LATEST Version]
  34. Corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. PMID: 10796635 [NOT CITED] [LATEST Version]
  35. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. PMID: 29553157 [CITED] [LATEST Version]
  36. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. PMID: 25491891 [NOT CITED] [OLD Version]
  37. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. PMID: 21975757 [NOT CITED] [OLD Version]
  38. Domicilary oxygen for chronic obstructive pulmonary disease. PMID: 10796666 [NOT CITED] [LATEST Version]
  39. Domiciliary oxygen for chronic obstructive pulmonary disease. PMID: 16235285 [NOT CITED] [LATEST Version]
  40. Domiciliary oxygen for chronic obstructive pulmonary disease. PMID: 11034726 [NOT CITED] [OLD Version]
  41. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 12535393 [NOT CITED] [LATEST Version]
  42. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 10796514 [NOT CITED] [OLD Version]
  43. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. PMID: 30521694 [NOT CITED] [LATEST Version]
  44. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. PMID: 28626902 [CITED] [LATEST Version]
  45. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. PMID: 25201571 [NOT CITED] [OLD Version]
  46. Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease. PMID: 31125127 [NOT CITED] [LATEST Version]
  47. Heliox for treatment of exacerbations of chronic obstructive pulmonary disease. PMID: 12076487 [NOT CITED] [LATEST Version]
  48. Home care by outreach nursing for chronic obstructive pulmonary disease. PMID: 22513899 [NOT CITED] [LATEST Version]
  49. Home care by outreach nursing for chronic obstructive pulmonary disease. PMID: 21412867 [NOT CITED] [OLD Version]
  50. Home care by outreach nursing for chronic obstructive pulmonary disease. PMID: 11686972 [NOT CITED] [OLD Version]
  51. Home care by outreach nursing for chronic obstructive pulmonary disease. PMID: 10796573 [NOT CITED] [OLD Version]
  52. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. PMID: 22592692 [NOT CITED] [LATEST Version]
  53. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. PMID: 14583984 [NOT CITED] [OLD Version]
  54. Hospital at home in chronic obstructive pulmonary disease: Is it a viable option? PMID: 22696389 [NOT CITED] [LATEST Version]
  55. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease. PMID: 25575340 [CITED] [LATEST Version]
  56. Influenza vaccine for chronic obstructive pulmonary disease (COPD). PMID: 29943802 [CITED] [LATEST Version]
  57. Influenza vaccine for patients with chronic obstructive pulmonary disease. PMID: 16437444 [NOT CITED] [LATEST Version]
  58. Influenza vaccine for patients with chronic obstructive pulmonary disease. PMID: 11034751 [NOT CITED] [OLD Version]
  59. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. PMID: 11869676 [NOT CITED] [LATEST Version]
  60. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. PMID: 22786484 [NOT CITED] [LATEST Version]
  61. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. PMID: 17443520 [NOT CITED] [OLD Version]
  62. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. PMID: 22161409 [CITED] [LATEST Version]
  63. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. PMID: 21975759 [NOT CITED] [OLD Version]
  64. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease. PMID: 27830584 [NOT CITED] [LATEST Version]
  65. Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease. PMID: 11406052 [NOT CITED] [LATEST Version]
  66. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. PMID: 24615270 [CITED] [LATEST Version]
  67. Inhaled tiotropium for stable chronic obstructive pulmonary disease. PMID: 15846642 [NOT CITED] [LATEST Version]
  68. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. PMID: 21069668 [NOT CITED] [LATEST Version]
  69. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. PMID: 17054135 [NOT CITED] [OLD Version]
  70. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. PMID: 24108523 [NOT CITED] [LATEST Version]
  71. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease. PMID: 16856113 [NOT CITED] [LATEST Version]
  72. Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease. PMID: 16625543 [NOT CITED] [LATEST Version]
  73. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease. PMID: 22513969 [NOT CITED] [LATEST Version]
  74. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. PMID: 26490945 [CITED] [LATEST Version]
  75. Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation. PMID: 12137617 [NOT CITED] [LATEST Version]
  76. Long-acting beta2-agonists for chronic obstructive pulmonary disease. PMID: 24127118 [NOT CITED] [LATEST Version]
  77. Long-acting beta2-agonists for chronic obstructive pulmonary disease. PMID: 10796594 [NOT CITED] [OLD Version]
  78. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. PMID: 16855959 [NOT CITED] [LATEST Version]
  79. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). PMID: 28185242 [CITED] [LATEST Version]
  80. Methyl-xanthines for exacerbations of chronic obstructive pulmonary disease. PMID: 11279755 [NOT CITED] [LATEST Version]
  81. Methylxanthines for exacerbations of chronic obstructive pulmonary disease. PMID: 12804425 [CITED] [LATEST Version]
  82. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 22895919 [NOT CITED] [LATEST Version]
  83. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 20166060 [NOT CITED] [OLD Version]
  84. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 16855965 [NOT CITED] [OLD Version]
  85. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 12804402 [NOT CITED] [OLD Version]
  86. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 10796634 [NOT CITED] [OLD Version]
  87. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 31107966 [NOT CITED] [LATEST Version]
  88. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 26222376 [NOT CITED] [OLD Version]
  89. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease. PMID: 29845600 [NOT CITED] [LATEST Version]
  90. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. PMID: 23766138 [NOT CITED] [LATEST Version]
  91. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. PMID: 12137664 [NOT CITED] [OLD Version]
  92. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 14974057 [NOT CITED] [OLD Version]
  93. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 15266518 [NOT CITED] [LATEST Version]
  94. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 12535509 [NOT CITED] [OLD Version]
  95. Non-invasive ventilation during exercise training for people with chronic obstructive pulmonary disease. PMID: 24823712 [CITED] [LATEST Version]
  96. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. PMID: 28702957 [NOT CITED] [LATEST Version]
  97. Nutritional supplementation for stable chronic obstructive pulmonary disease. PMID: 23235577 [CITED] [LATEST Version]
  98. Nutritional supplementation for stable chronic obstructive pulmonary disease. PMID: 15846608 [NOT CITED] [OLD Version]
  99. Nutritional supplementation for stable chronic obstructive pulmonary disease. PMID: 11869582 [NOT CITED] [OLD Version]
  100. Nutritional supplementation in stable chronic obstructive pulmonary disease. PMID: 10908481 [NOT CITED] [LATEST Version]
  101. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. PMID: 30839102 [NOT CITED] [LATEST Version]
  102. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease. PMID: 30141826 [NOT CITED] [LATEST Version]
  103. Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease. PMID: 22071841 [CITED] [LATEST Version]
  104. Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. PMID: 11405984 [NOT CITED] [LATEST Version]
  105. Oral corticosteroids for stable chronic obstructive pulmonary disease. PMID: 16034972 [NOT CITED] [LATEST Version]
  106. Oral theophylline for chronic obstructive pulmonary disease. PMID: 12519617 [NOT CITED] [LATEST Version]
  107. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. PMID: 27886372 [CITED] [LATEST Version]
  108. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. PMID: 17443585 [NOT CITED] [LATEST Version]
  109. Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease. PMID: 16856102 [NOT CITED] [LATEST Version]
  110. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. PMID: 22071851 [NOT CITED] [LATEST Version]
  111. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. PMID: 30566235 [NOT CITED] [LATEST Version]
  112. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. PMID: 28922692 [CITED] [LATEST Version]
  113. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. PMID: 24190161 [NOT CITED] [OLD Version]
  114. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. PMID: 21833986 [NOT CITED] [OLD Version]
  115. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. PMID: 21563134 [NOT CITED] [OLD Version]
  116. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. PMID: 28116747 [NOT CITED] [LATEST Version]
  117. Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease. PMID: 11869627 [NOT CITED] [LATEST Version]
  118. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). PMID: 30376188 [CITED] [LATEST Version]
  119. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). PMID: 24288145 [NOT CITED] [OLD Version]
  120. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. PMID: 28322440 [NOT CITED] [LATEST Version]
  121. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease. PMID: 30838649 [NOT CITED] [LATEST Version]
  122. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. PMID: 27930803 [CITED] [LATEST Version]
  123. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. PMID: 21975749 [NOT CITED] [OLD Version]
  124. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. PMID: 19160250 [NOT CITED] [OLD Version]
  125. Pulmonary rehabilitation for chronic obstructive pulmonary disease. PMID: 25705944 [CITED] [LATEST Version]
  126. Pulmonary rehabilitation for chronic obstructive pulmonary disease. PMID: 17054186 [NOT CITED] [OLD Version]
  127. Pulmonary rehabilitation for chronic obstructive pulmonary disease. PMID: 12137716 [NOT CITED] [OLD Version]
  128. Self management for patients with chronic obstructive pulmonary disease. PMID: 24665053 [NOT CITED] [LATEST Version]
  129. Self-management education for chronic obstructive pulmonary disease. PMID: 12535447 [NOT CITED] [LATEST Version]
  130. Self-management education for patients with chronic obstructive pulmonary disease. PMID: 17943778 [NOT CITED] [LATEST Version]
  131. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. PMID: 28777450 [CITED] [LATEST Version]
  132. Short term ambulatory oxygen for chronic obstructive pulmonary disease. PMID: 15846710 [NOT CITED] [LATEST Version]
  133. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease. PMID: 12519559 [NOT CITED] [LATEST Version]
  134. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease. PMID: 10796652 [NOT CITED] [OLD Version]
  135. Short-term ambulatory oxygen for chronic obstructive pulmonary disease. PMID: 16235359 [CITED] [LATEST Version]
  136. Singing for adults with chronic obstructive pulmonary disease (COPD). PMID: 29253921 [NOT CITED] [LATEST Version]
  137. Smoking cessation for chronic obstructive pulmonary disease. PMID: 12804448 [NOT CITED] [LATEST Version]
  138. Smoking cessation for people with chronic obstructive pulmonary disease. PMID: 27545342 [CITED] [LATEST Version]
  139. Statins versus placebo for people with chronic obstructive pulmonary disease. PMID: 31425628 [NOT CITED] [LATEST Version]
  140. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. PMID: 21678356 [NOT CITED] [LATEST Version]
  141. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. PMID: 25178099 [CITED] [LATEST Version]
  142. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. PMID: 19160195 [NOT CITED] [OLD Version]
  143. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. PMID: 15674875 [NOT CITED] [OLD Version]
  144. Tai Chi for chronic obstructive pulmonary disease (COPD). PMID: 27272131 [CITED] [LATEST Version]
  145. Telehealthcare for chronic obstructive pulmonary disease. PMID: 21735417 [CITED] [LATEST Version]
  146. The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease. PMID: 21901729 [NOT CITED] [LATEST Version]
  147. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease. PMID: 26391969 [CITED] [LATEST Version]
  148. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease. PMID: 24043433 [NOT CITED] [OLD Version]
  149. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. PMID: 22972134 [NOT CITED] [LATEST Version]
  150. Tiotropium versus placebo for chronic obstructive pulmonary disease. PMID: 25046211 [CITED] [LATEST Version]
  151. Tiotropium versus placebo for chronic obstructive pulmonary disease. PMID: 22786525 [NOT CITED] [OLD Version]
  152. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD). PMID: 28631387 [CITED] [LATEST Version]
  153. Water-based exercise training for chronic obstructive pulmonary disease. PMID: 24353107 [CITED] [LATEST Version]
2078 Q6488975 large-cell lung carcinoma Large-cell lung carcinoma C 2-High

Hematology-oncology

Pathology

Pulmonology

 No matching publication found!
1896 Q3658562 non-small-cell lung carcinoma Non-small-cell lung carcinoma C 2-High

Hematology-oncology

Pathology

Pulmonology
  1. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease. PMID: 17943820 [NOT CITED] [LATEST Version]
4197 Q843799 adenocarcinoma of the lung Adenocarcinoma of the lung C 2-High

Hematology-oncology

Pathology

Pulmonology

 No matching publication found!
1315 Q614750 bronchiolitis obliterans Bronchiolitis obliterans C 2-High

Pulmonology
  1. Antibody induction therapy for lung transplant recipients. PMID: 24282128 [NOT CITED] [LATEST Version]
  2. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. PMID: 23728681 [NOT CITED] [LATEST Version]
1144 Q3286546 respiratory system disease Respiratory disease Start 2-High

Pulmonology
  1. Anti-histamines for prolonged non-specific cough in children. PMID: 18425925 [NOT CITED] [LATEST Version]
  2. Anti-histamines for prolonged non-specific cough in children. PMID: 16856107 [NOT CITED] [OLD Version]
  3. Caseworker-assigned discharge plans to prevent hospital readmission for acute exacerbations in children with chronic respiratory illness. PMID: 30387126 [NOT CITED] [LATEST Version]
  4. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). PMID: 23076910 [NOT CITED] [LATEST Version]
  5. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). PMID: 16437501 [NOT CITED] [OLD Version]
  6. Clinical pathways for chronic cough in children. PMID: 25242448 [NOT CITED] [LATEST Version]
  7. Clinical pathways for chronic cough in children. PMID: 18425958 [NOT CITED] [OLD Version]
  8. Dual antibiotics for bronchiectasis. PMID: 29889304 [NOT CITED] [LATEST Version]
  9. Duration of intravenous antibiotic therapy in people with cystic fibrosis. PMID: 27582394 [NOT CITED] [LATEST Version]
  10. Duration of intravenous antibiotic therapy in people with cystic fibrosis. PMID: 23728662 [NOT CITED] [OLD Version]
  11. Duration of intravenous antibiotic therapy in people with cystic fibrosis. PMID: 21249681 [NOT CITED] [OLD Version]
  12. Duration of intravenous antibiotic therapy in people with cystic fibrosis. PMID: 18425963 [NOT CITED] [OLD Version]
  13. Exercise training to improve exercise capacity and quality of life in people with non-malignant dust-related respiratory diseases. PMID: 26544672 [NOT CITED] [LATEST Version]
  14. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. PMID: 21249664 [NOT CITED] [LATEST Version]
  15. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. PMID: 17054216 [NOT CITED] [OLD Version]
  16. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. PMID: 15846735 [NOT CITED] [OLD Version]
  17. Honey and lozenges for children with non-specific cough. PMID: 19370690 [NOT CITED] [LATEST Version]
  18. Housing improvements for health and associated socio-economic outcomes. PMID: 23450585 [NOT CITED] [LATEST Version]
  19. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. PMID: 19160285 [NOT CITED] [LATEST Version]
  20. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease. PMID: 25575340 [NOT CITED] [LATEST Version]
  21. Indoor air modification interventions for prolonged non-specific cough in children. PMID: 16856075 [NOT CITED] [LATEST Version]
  22. Inhaled anti-cholinergics for prolonged non-specific cough in children. PMID: 14974067 [NOT CITED] [LATEST Version]
  23. Inhaled corticosteroids for non-specific chronic cough in children. PMID: 16235355 [NOT CITED] [LATEST Version]
  24. Inhaled corticosteroids for subacute and chronic cough in adults. PMID: 23543575 [NOT CITED] [LATEST Version]
  25. Inhaled cromones for prolonged non-specific cough in children. PMID: 15106252 [NOT CITED] [LATEST Version]
  26. Inhaled long acting beta agonists for stable chronic asthma. PMID: 14583933 [NOT CITED] [LATEST Version]
  27. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 28045472 [NOT CITED] [LATEST Version]
  28. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 21154346 [NOT CITED] [OLD Version]
  29. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 17636641 [NOT CITED] [OLD Version]
  30. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. PMID: 26171905 [NOT CITED] [LATEST Version]
  31. Interventions for promoting physical activity in people with cystic fibrosis. PMID: 24338214 [NOT CITED] [LATEST Version]
  32. Interventions for the interruption or reduction of the spread of respiratory viruses. PMID: 17943895 [NOT CITED] [LATEST Version]
  33. Leukotriene receptor antagonist for prolonged non-specific cough in children. PMID: 16625643 [NOT CITED] [LATEST Version]
  34. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. PMID: 17253458 [NOT CITED] [LATEST Version]
  35. Long-acting beta2-agonists for chronic obstructive pulmonary disease. PMID: 24127118 [NOT CITED] [LATEST Version]
  36. Macrolide antibiotics for bronchiectasis. PMID: 29543980 [NOT CITED] [LATEST Version]
  37. Methylxanthines for prolonged non-specific cough in children. PMID: 16034969 [NOT CITED] [LATEST Version]
  38. Nebulised hypertonic saline for cystic fibrosis. PMID: 10796798 [NOT CITED] [LATEST Version]
  39. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. PMID: 27748503 [NOT CITED] [LATEST Version]
  40. Oral health education (advice and training) for people with serious mental illness. PMID: 27606629 [NOT CITED] [LATEST Version]
  41. Orthodontic treatment for posterior crossbites. PMID: 11279699 [NOT CITED] [LATEST Version]
  42. Orthodontic treatment for posterior crossbites. PMID: 10796568 [NOT CITED] [OLD Version]
  43. Physical interventions to interrupt or reduce the spread of respiratory viruses. PMID: 21735402 [NOT CITED] [LATEST Version]
  44. Physical interventions to interrupt or reduce the spread of respiratory viruses. PMID: 20091588 [NOT CITED] [OLD Version]
  45. Prenatal thyrotropin-releasing hormone for preterm birth. PMID: 10796087 [NOT CITED] [LATEST Version]
  46. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. PMID: 27315509 [NOT CITED] [LATEST Version]
  47. Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy. PMID: 26058963 [NOT CITED] [LATEST Version]
  48. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. PMID: 17636741 [NOT CITED] [LATEST Version]
  49. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. PMID: 12917996 [NOT CITED] [OLD Version]
  50. Restriction of oral intake of water for aspiration lung disease in children. PMID: 22972084 [NOT CITED] [LATEST Version]
  51. Restriction of oral intake of water for aspiration lung disease in children. PMID: 16235398 [NOT CITED] [OLD Version]
  52. Singing for children and adults with bronchiectasis. PMID: 20166097 [NOT CITED] [LATEST Version]
  53. Statins versus placebo for people with chronic obstructive pulmonary disease. PMID: 31425628 [NOT CITED] [LATEST Version]
  54. Sublingual immunotherapy for asthma. PMID: 26315994 [NOT CITED] [LATEST Version]
  55. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. PMID: 24265169 [NOT CITED] [LATEST Version]
  56. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. PMID: 15106139 [NOT CITED] [OLD Version]
  57. Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age. PMID: 21154399 [NOT CITED] [LATEST Version]
  58. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. PMID: 28282701 [NOT CITED] [LATEST Version]
  59. Water-based exercise training for chronic obstructive pulmonary disease. PMID: 24353107 [NOT CITED] [LATEST Version]
2417 Q738170 small cell carcinoma Small-cell carcinoma C 2-High

Hematology-oncology

Pathology

Pulmonology

 No matching publication found!
127 Q173022 bronchitis Bronchitis B 2-High

Pulmonology
  1. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. PMID: 23728642 [NOT CITED] [LATEST Version]
  2. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. PMID: 19160217 [NOT CITED] [OLD Version]
  3. Airway clearance techniques for chronic obstructive pulmonary disease. PMID: 22419331 [NOT CITED] [LATEST Version]
  4. Antibiotics for acute bronchitis. PMID: 28626858 [CITED] [LATEST Version]
  5. Antibiotics for acute bronchitis. PMID: 24585130 [NOT CITED] [OLD Version]
  6. Antibiotics for acute bronchitis. PMID: 15494994 [NOT CITED] [OLD Version]
  7. Antibiotics for acute bronchitis. PMID: 10796516 [NOT CITED] [OLD Version]
  8. Antibiotics for acute bronchitis. PMID: 11034678 [NOT CITED] [OLD Version]
  9. Antibiotics for prolonged wet cough in children. PMID: 30062732 [CITED] [LATEST Version]
  10. Azithromycin for acute lower respiratory tract infections. PMID: 25749735 [NOT CITED] [LATEST Version]
  11. Azithromycin for acute lower respiratory tract infections. PMID: 18253999 [NOT CITED] [OLD Version]
  12. Azithromycin for acute lower respiratory tract infections. PMID: 15497172 [NOT CITED] [OLD Version]
  13. Beta2-agonists for acute bronchitis. PMID: 21735384 [NOT CITED] [LATEST Version]
  14. Beta2-agonists for acute bronchitis. PMID: 17054140 [NOT CITED] [OLD Version]
  15. Beta2-agonists for acute bronchitis. PMID: 14973971 [NOT CITED] [OLD Version]
  16. Beta2-agonists for acute bronchitis. PMID: 11279725 [NOT CITED] [OLD Version]
  17. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. PMID: 26333656 [CITED] [LATEST Version]
  18. Chinese medicinal herbs for acute bronchitis. PMID: 22336804 [CITED] [LATEST Version]
  19. Chinese medicinal herbs for acute bronchitis. PMID: 18254054 [NOT CITED] [OLD Version]
  20. Chinese medicinal herbs for acute bronchitis. PMID: 16034937 [NOT CITED] [OLD Version]
  21. Delayed antibiotics for respiratory infections. PMID: 23633320 [NOT CITED] [LATEST Version]
  22. Delayed antibiotics for respiratory infections. PMID: 17636757 [NOT CITED] [OLD Version]
  23. Delayed antibiotics for symptoms and complications of respiratory infections. PMID: 15495108 [NOT CITED] [LATEST Version]
  24. Educational outreach visits: effects on professional practice and health care outcomes. PMID: 10796542 [NOT CITED] [LATEST Version]
  25. Haemophilus influenzae oral vaccination against acute bronchitis. PMID: 10796676 [NOT CITED] [LATEST Version]
  26. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. PMID: 28626902 [NOT CITED] [LATEST Version]
  27. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. PMID: 25201571 [NOT CITED] [OLD Version]
  28. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. PMID: 17054150 [NOT CITED] [LATEST Version]
  29. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. PMID: 12917917 [NOT CITED] [OLD Version]
  30. Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease. PMID: 31125127 [NOT CITED] [LATEST Version]
  31. Inhaled corticosteroids for subacute and chronic cough in adults. PMID: 23543575 [NOT CITED] [LATEST Version]
  32. Inhaled hyperosmolar agents for bronchiectasis. PMID: 16625566 [NOT CITED] [LATEST Version]
  33. Inhaled hyperosmolar agents for bronchiectasis. PMID: 11869647 [NOT CITED] [OLD Version]
  34. Inhaled hyperosmolar agents for bronchiectasis. PMID: 11406058 [NOT CITED] [OLD Version]
  35. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 22895919 [NOT CITED] [LATEST Version]
  36. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 20166060 [NOT CITED] [OLD Version]
  37. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 16855965 [NOT CITED] [OLD Version]
  38. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 12804402 [NOT CITED] [OLD Version]
  39. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 10796634 [NOT CITED] [OLD Version]
  40. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 31107966 [CITED] [LATEST Version]
  41. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. PMID: 26222376 [NOT CITED] [OLD Version]
  42. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. PMID: 24718923 [NOT CITED] [LATEST Version]
  43. Pelargonium sidoides extract for acute respiratory tract infections. PMID: 18646148 [NOT CITED] [LATEST Version]
  44. Pelargonium sidoides extract for treating acute respiratory tract infections. PMID: 24146345 [NOT CITED] [LATEST Version]
  45. Prophylactic antibiotic therapy for chronic bronchitis. PMID: 12535510 [NOT CITED] [LATEST Version]
  46. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. PMID: 28322440 [NOT CITED] [LATEST Version]
  47. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. PMID: 23728681 [NOT CITED] [LATEST Version]
4558 Q32778 bronchiectasis Bronchiectasis C 2-High

Pulmonology
  1. Airway clearance techniques for bronchiectasis. PMID: 26591003 [CITED] [LATEST Version]
  2. Airway clearance techniques for bronchiectasis. PMID: 23728674 [NOT CITED] [OLD Version]
  3. Antibiotics for prolonged moist cough in children. PMID: 16235384 [NOT CITED] [LATEST Version]
  4. Antibiotics for prolonged wet cough in children. PMID: 30062732 [NOT CITED] [LATEST Version]
  5. Anticholinergic therapy for bronchiectasis. PMID: 11687147 [CITED] [LATEST Version]
  6. Antioxidant supplementation for lung disease in cystic fibrosis. PMID: 31580490 [NOT CITED] [LATEST Version]
  7. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. PMID: 10796474 [NOT CITED] [LATEST Version]
  8. Caseworker-assigned discharge plans to prevent hospital readmission for acute exacerbations in children with chronic respiratory illness. PMID: 30387126 [NOT CITED] [LATEST Version]
  9. Codeine versus placebo for chronic cough in children. PMID: 27405706 [NOT CITED] [LATEST Version]
  10. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis. PMID: 24913725 [NOT CITED] [LATEST Version]
  11. Continuous versus intermittent antibiotics for bronchiectasis. PMID: 29860722 [NOT CITED] [LATEST Version]
  12. Dual antibiotics for bronchiectasis. PMID: 29889304 [NOT CITED] [LATEST Version]
  13. Head-to-head trials of antibiotics for bronchiectasis. PMID: 30184243 [NOT CITED] [LATEST Version]
  14. Influenza vaccine for children and adults with bronchiectasis. PMID: 17636836 [NOT CITED] [LATEST Version]
  15. Inhaled corticosteroids for bronchiectasis. PMID: 29766487 [CITED] [LATEST Version]
  16. Inhaled hyperosmolar agents for bronchiectasis. PMID: 24817558 [NOT CITED] [LATEST Version]
  17. Inhaled hyperosmolar agents for bronchiectasis. PMID: 16625566 [NOT CITED] [OLD Version]
  18. Inhaled hyperosmolar agents for bronchiectasis. PMID: 11869647 [NOT CITED] [OLD Version]
  19. Inhaled hyperosmolar agents for bronchiectasis. PMID: 11406058 [NOT CITED] [OLD Version]
  20. Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis. PMID: 26816298 [NOT CITED] [LATEST Version]
  21. Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis. PMID: 20393960 [NOT CITED] [OLD Version]
  22. Inhaled steroids for bronchiectasis. PMID: 19160186 [CITED] [LATEST Version]
  23. Inhaled steroids for bronchiectasis. PMID: 10796575 [NOT CITED] [OLD Version]
  24. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. PMID: 26171905 [NOT CITED] [LATEST Version]
  25. Interventions for enhancing adherence to treatment in adults with bronchiectasis. PMID: 26576499 [NOT CITED] [LATEST Version]
  26. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. PMID: 11034744 [NOT CITED] [LATEST Version]
  27. Long-acting beta-2-agonists for bronchiectasis. PMID: 11687145 [NOT CITED] [LATEST Version]
  28. Macrolide antibiotics for bronchiectasis. PMID: 29543980 [NOT CITED] [LATEST Version]
  29. Mucolytics for bronchiectasis. PMID: 24789119 [NOT CITED] [LATEST Version]
  30. Mucolytics for bronchiectasis. PMID: 11279712 [NOT CITED] [OLD Version]
  31. Mucolytics for bronchiectasis. PMID: 10796636 [NOT CITED] [OLD Version]
  32. Nurse specialist care for bronchiectasis. PMID: 12918011 [NOT CITED] [LATEST Version]
  33. Nurse-led versus doctor-led care for bronchiectasis. PMID: 29926473 [NOT CITED] [LATEST Version]
  34. Oral methyl-xanthines for bronchiectasis. PMID: 11279764 [NOT CITED] [LATEST Version]
  35. Oral non steroid anti-inflammatories for children and adults with bronchiectasis. PMID: 17943909 [NOT CITED] [LATEST Version]
  36. Oral steroids for bronchiectasis (stable and acute exacerbations). PMID: 11687146 [NOT CITED] [LATEST Version]
  37. Oral steroids for cystic fibrosis. PMID: 10796717 [NOT CITED] [LATEST Version]
  38. Oral versus inhaled antibiotics for bronchiectasis. PMID: 29587336 [NOT CITED] [LATEST Version]
  39. Physical training for bronchiectasis. PMID: 12137647 [NOT CITED] [LATEST Version]
  40. Pneumococcal vaccines for children and adults with bronchiectasis. PMID: 19370631 [NOT CITED] [LATEST Version]
  41. Pneumococcal vaccines for children and adults with bronchiectasis. PMID: 17443619 [NOT CITED] [OLD Version]
  42. Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis. PMID: 28952156 [NOT CITED] [LATEST Version]
  43. Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults. PMID: 26270620 [CITED] [LATEST Version]
  44. Prolonged antibiotics for purulent bronchiectasis in children and adults. PMID: 17443506 [NOT CITED] [LATEST Version]
  45. Prolonged antibiotics for purulent bronchiectasis. PMID: 14583934 [NOT CITED] [LATEST Version]
  46. Self-management for bronchiectasis. PMID: 29411860 [NOT CITED] [LATEST Version]
  47. Short acting beta-2 agonists for bronchiectasis. PMID: 12917973 [NOT CITED] [LATEST Version]
  48. Short courses of antibiotics for children and adults with bronchiectasis. PMID: 21678381 [NOT CITED] [LATEST Version]
  49. Singing for children and adults with bronchiectasis. PMID: 20166097 [NOT CITED] [LATEST Version]
  50. Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids. PMID: 25997166 [NOT CITED] [LATEST Version]
  51. Surgery vs non-surgical treatment for bronchiectasis. PMID: 11034745 [CITED] [LATEST Version]
243 Q213600 sleep apnea Sleep apnea C 2-High

Neurology

Pulmonology
  1. Anti-inflammatory medications for obstructive sleep apnea in children. PMID: 21249687 [NOT CITED] [LATEST Version]
  2. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI. PMID: 26943923 [NOT CITED] [LATEST Version]
  3. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. PMID: 28982219 [NOT CITED] [LATEST Version]
  4. Opioids compared to placebo or other treatments for chronic low-back pain. PMID: 23983011 [NOT CITED] [LATEST Version]
214 Q220570 pulmonary embolism Pulmonary embolism B 2-High

Cardiology

Pulmonology
  1. Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery. PMID: 14583989 [NOT CITED] [LATEST Version]
  2. Anticoagulant treatment for subsegmental pulmonary embolism. PMID: 26756331 [CITED] [LATEST Version]
  3. Anticoagulant treatment for subsegmental pulmonary embolism. PMID: 24771493 [NOT CITED] [OLD Version]
  4. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. PMID: 27027384 [NOT CITED] [LATEST Version]
  5. Anticoagulants for acute ischaemic stroke. PMID: 25764172 [NOT CITED] [LATEST Version]
  6. Anticoagulants for acute ischaemic stroke. PMID: 18843603 [NOT CITED] [OLD Version]
  7. Anticoagulants for acute ischaemic stroke. PMID: 15266421 [NOT CITED] [OLD Version]
  8. Anticoagulation for cerebral sinus thrombosis. PMID: 12519565 [NOT CITED] [LATEST Version]
  9. Anticoagulation for cerebral venous sinus thrombosis. PMID: 21833941 [NOT CITED] [LATEST Version]
  10. Anticoagulation for heart failure in sinus rhythm. PMID: 11687190 [NOT CITED] [LATEST Version]
  11. Anticoagulation for people with cancer and central venous catheters. PMID: 29856471 [NOT CITED] [LATEST Version]
  12. Anticoagulation for perioperative thromboprophylaxis in people with cancer. PMID: 29993117 [NOT CITED] [LATEST Version]
  13. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. PMID: 17636845 [NOT CITED] [LATEST Version]
  14. Anticoagulation versus placebo for heart failure in sinus rhythm. PMID: 24683002 [NOT CITED] [LATEST Version]
  15. Anticoagulation versus placebo for heart failure in sinus rhythm. PMID: 22696335 [NOT CITED] [OLD Version]
  16. Antifibrinolytic drugs for acute traumatic injury. PMID: 25956410 [NOT CITED] [LATEST Version]
  17. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. PMID: 27629776 [NOT CITED] [LATEST Version]
  18. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. PMID: 18843686 [NOT CITED] [LATEST Version]
  19. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. PMID: 27600864 [NOT CITED] [LATEST Version]
  20. Combined oral contraceptives: venous thrombosis. PMID: 24590565 [NOT CITED] [LATEST Version]
  21. Compression stockings for preventing deep vein thrombosis in airline passengers. PMID: 27624857 [NOT CITED] [LATEST Version]
  22. Compression therapy for prevention of post-thrombotic syndrome. PMID: 28950030 [NOT CITED] [LATEST Version]
  23. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty. PMID: 25069620 [NOT CITED] [LATEST Version]
  24. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty. PMID: 22258981 [NOT CITED] [OLD Version]
  25. D-dimer test for excluding the diagnosis of pulmonary embolism. PMID: 27494075 [NOT CITED] [LATEST Version]
  26. Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement. PMID: 25528992 [NOT CITED] [LATEST Version]
  27. Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement. PMID: 23152279 [NOT CITED] [OLD Version]
  28. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE. PMID: 25749503 [NOT CITED] [LATEST Version]
  29. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. PMID: 28832905 [NOT CITED] [LATEST Version]
  30. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. PMID: 30407621 [NOT CITED] [LATEST Version]
  31. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. PMID: 28182249 [CITED] [LATEST Version]
  32. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. PMID: 10796593 [NOT CITED] [LATEST Version]
  33. Graduated compression stockings for prevention of deep vein thrombosis. PMID: 30390397 [NOT CITED] [LATEST Version]
  34. Haemodilution for acute ischaemic stroke. PMID: 25159027 [NOT CITED] [LATEST Version]
  35. Haemodilution for acute ischaemic stroke. PMID: 12519536 [NOT CITED] [OLD Version]
  36. Haemodilution for acute ischaemic stroke. PMID: 10796299 [NOT CITED] [OLD Version]
  37. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). PMID: 24804622 [NOT CITED] [LATEST Version]
  38. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). PMID: 19588346 [NOT CITED] [LATEST Version]
  39. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. PMID: 12519540 [NOT CITED] [LATEST Version]
  40. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. PMID: 10796339 [NOT CITED] [OLD Version]
  41. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. PMID: 14583929 [NOT CITED] [LATEST Version]
  42. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. PMID: 11686983 [NOT CITED] [OLD Version]
  43. Home versus in-patient treatment for deep vein thrombosis. PMID: 29315455 [NOT CITED] [LATEST Version]
  44. Home versus in-patient treatment for deep vein thrombosis. PMID: 11406067 [NOT CITED] [OLD Version]
  45. Hormone therapy for preventing cardiovascular disease in post-menopausal women. PMID: 25754617 [NOT CITED] [LATEST Version]
  46. Hormone therapy for preventing cardiovascular disease in post-menopausal women. PMID: 23633307 [NOT CITED] [OLD Version]
  47. Imaging for the exclusion of pulmonary embolism in pregnancy. PMID: 28124411 [NOT CITED] [LATEST Version]
  48. Interventions for lowering plasma homocysteine levels in dialysis patients. PMID: 27243372 [NOT CITED] [LATEST Version]
  49. Interventions for preventing venous thromboembolism following abdominal aortic surgery. PMID: 18254082 [NOT CITED] [LATEST Version]
  50. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. PMID: 18843687 [NOT CITED] [LATEST Version]
  51. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. PMID: 17443578 [NOT CITED] [OLD Version]
  52. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children. PMID: 24615288 [NOT CITED] [LATEST Version]
  53. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization. PMID: 28780771 [NOT CITED] [LATEST Version]
  54. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. PMID: 24966161 [NOT CITED] [LATEST Version]
  55. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. PMID: 22071865 [NOT CITED] [OLD Version]
  56. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 28374884 [NOT CITED] [LATEST Version]
  57. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 18646059 [NOT CITED] [OLD Version]
  58. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 15846600 [NOT CITED] [OLD Version]
  59. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 11687069 [NOT CITED] [OLD Version]
  60. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. PMID: 10796301 [NOT CITED] [OLD Version]
  61. Neuromuscular electrical stimulation for the prevention of venous thromboembolism. PMID: 29161465 [NOT CITED] [LATEST Version]
  62. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. PMID: 14974060 [NOT CITED] [LATEST Version]
  63. Nutritional supplementation for hip fracture aftercare in older people. PMID: 27898998 [NOT CITED] [LATEST Version]
  64. Oral anticoagulation for prolonging survival in patients with cancer. PMID: 17443622 [NOT CITED] [LATEST Version]
  65. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. PMID: 29285754 [NOT CITED] [LATEST Version]
  66. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. PMID: 26123214 [NOT CITED] [LATEST Version]
  67. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. PMID: 26636644 [NOT CITED] [LATEST Version]
  68. Outpatient versus inpatient treatment for acute pulmonary embolism. PMID: 30839095 [NOT CITED] [LATEST Version]
  69. Outpatient versus inpatient treatment for acute pulmonary embolism. PMID: 25411774 [NOT CITED] [OLD Version]
  70. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. PMID: 17636846 [NOT CITED] [LATEST Version]
  71. Parenteral anticoagulation in ambulatory patients with cancer. PMID: 28892556 [NOT CITED] [LATEST Version]
  72. Parenteral anticoagulation in ambulatory patients with cancer. PMID: 25491949 [NOT CITED] [OLD Version]
  73. Pentasaccharides for the prevention of venous thromboembolism. PMID: 27797404 [NOT CITED] [LATEST Version]
  74. Physical methods for preventing deep vein thrombosis in stroke. PMID: 20687069 [NOT CITED] [LATEST Version]
  75. Physical methods for preventing deep vein thrombosis in stroke. PMID: 15495020 [NOT CITED] [OLD Version]
  76. Physical methods for preventing deep vein thrombosis in stroke. PMID: 11869611 [NOT CITED] [OLD Version]
  77. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. PMID: 30484282 [NOT CITED] [LATEST Version]
  78. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. PMID: 30019767 [NOT CITED] [OLD Version]
  79. Postoperative tamoxifen for ductal carcinoma in situ. PMID: 23076938 [NOT CITED] [LATEST Version]
  80. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. PMID: 22336844 [NOT CITED] [LATEST Version]
  81. Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. PMID: 26091835 [NOT CITED] [LATEST Version]
  82. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity. PMID: 24343728 [NOT CITED] [LATEST Version]
  83. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. PMID: 31449321 [NOT CITED] [LATEST Version]
  84. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. PMID: 30916777 [NOT CITED] [OLD Version]
  85. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. PMID: 30481366 [NOT CITED] [OLD Version]
  86. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. PMID: 19160234 [NOT CITED] [OLD Version]
  87. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. PMID: 28005272 [NOT CITED] [LATEST Version]
  88. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. PMID: 24297507 [NOT CITED] [OLD Version]
  89. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. PMID: 24519568 [NOT CITED] [LATEST Version]
  90. Prostacyclin for pulmonary arterial hypertension. PMID: 31042010 [NOT CITED] [LATEST Version]
  91. Rutosides for treatment of post-thrombotic syndrome. PMID: 30406640 [NOT CITED] [LATEST Version]
  92. Rutosides for treatment of post-thrombotic syndrome. PMID: 26376212 [NOT CITED] [OLD Version]
  93. Rutosides for treatment of post-thrombotic syndrome. PMID: 23633330 [NOT CITED] [OLD Version]
  94. Statins for primary prevention of venous thromboembolism. PMID: 25518837 [NOT CITED] [LATEST Version]
  95. Statins for primary prevention of venous thromboembolism. PMID: 22161421 [NOT CITED] [OLD Version]
  96. Strontium ranelate for preventing and treating postmenopausal osteoporosis. PMID: 16856092 [NOT CITED] [LATEST Version]
  97. Subacromial decompression surgery for rotator cuff disease. PMID: 30707445 [NOT CITED] [LATEST Version]
  98. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. PMID: 28195640 [NOT CITED] [LATEST Version]
  99. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. PMID: 19821386 [NOT CITED] [OLD Version]
  100. Surgery for obesity. PMID: 19370590 [NOT CITED] [LATEST Version]
  101. Surgical interventions for symptomatic mild to moderate knee osteoarthritis. PMID: 31322289 [NOT CITED] [LATEST Version]
  102. Surgical versus nonsurgical interventions for flail chest. PMID: 26222250 [NOT CITED] [LATEST Version]
  103. Thrombolysis for acute deep vein thrombosis. PMID: 27830895 [NOT CITED] [LATEST Version]
  104. Thrombolysis for acute deep vein thrombosis. PMID: 24452314 [NOT CITED] [OLD Version]
  105. Thrombolysis for acute deep vein thrombosis. PMID: 15495034 [NOT CITED] [OLD Version]
  106. Thrombolysis for acute upper extremity deep vein thrombosis. PMID: 29226949 [NOT CITED] [LATEST Version]
  107. Thrombolytic therapy for pulmonary embolism. PMID: 30560579 [CITED] [LATEST Version]
  108. Thrombolytic therapy for pulmonary embolism. PMID: 26419832 [NOT CITED] [OLD Version]
  109. Thrombolytic therapy for pulmonary embolism. PMID: 19588357 [NOT CITED] [OLD Version]
  110. Thrombolytic therapy for pulmonary embolism. PMID: 16625603 [NOT CITED] [OLD Version]
  111. Thromboprophylaxis for trauma patients. PMID: 23543562 [NOT CITED] [LATEST Version]
  112. Topical application of tranexamic acid for the reduction of bleeding. PMID: 23881695 [NOT CITED] [LATEST Version]
  113. Tranexamic acid for reducing mortality in emergency and urgent surgery. PMID: 23440847 [NOT CITED] [LATEST Version]
  114. Tranexamic acid for upper gastrointestinal bleeding. PMID: 22258969 [NOT CITED] [LATEST Version]
  115. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. PMID: 22972111 [NOT CITED] [LATEST Version]
  116. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients. PMID: 28431186 [NOT CITED] [LATEST Version]
  117. Vena caval filters for the prevention of pulmonary embolism. PMID: 20166079 [CITED] [LATEST Version]
  118. Vena caval filters for the prevention of pulmonary embolism. PMID: 17943896 [NOT CITED] [OLD Version]
  119. Vena caval filters for the prevention of pulmonary embolism. PMID: 17636834 [NOT CITED] [OLD Version]
  120. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. PMID: 23076894 [NOT CITED] [LATEST Version]
  121. Warfarin initiation nomograms for venous thromboembolism. PMID: 26822633 [NOT CITED] [LATEST Version]
  122. Warfarin initiation nomograms for venous thromboembolism. PMID: 23839808 [NOT CITED] [OLD Version]
154 Q178194 cystic fibrosis Cystic fibrosis B 2-High

Medical genetics

Pulmonology
  1. Active cycle of breathing technique for cystic fibrosis. PMID: 27378490 [NOT CITED] [LATEST Version]
  2. Active cycle of breathing technique for cystic fibrosis. PMID: 23235649 [NOT CITED] [OLD Version]
  3. Active cycle of breathing technique for cystic fibrosis. PMID: 21069699 [NOT CITED] [OLD Version]
  4. Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews. PMID: 30676656 [NOT CITED] [LATEST Version]
  5. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 29551015 [NOT CITED] [LATEST Version]
  6. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 26545165 [NOT CITED] [OLD Version]
  7. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 24043500 [NOT CITED] [OLD Version]
  8. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis. PMID: 26798057 [NOT CITED] [LATEST Version]
  9. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis. PMID: 22419317 [NOT CITED] [OLD Version]
  10. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis. PMID: 23737089 [CITED] [LATEST Version]
  11. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis. PMID: 20927769 [NOT CITED] [OLD Version]
  12. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. PMID: 28440853 [CITED] [LATEST Version]
  13. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. PMID: 25383937 [NOT CITED] [OLD Version]
  14. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. PMID: 19821321 [NOT CITED] [OLD Version]
  15. Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis. PMID: 31194880 [NOT CITED] [LATEST Version]
  16. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. PMID: 26789750 [NOT CITED] [LATEST Version]
  17. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. PMID: 23076960 [NOT CITED] [OLD Version]
  18. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. PMID: 28000919 [NOT CITED] [LATEST Version]
  19. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. PMID: 25470304 [NOT CITED] [OLD Version]
  20. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. PMID: 23235684 [NOT CITED] [OLD Version]
  21. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. PMID: 27415821 [NOT CITED] [LATEST Version]
  22. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. PMID: 24696136 [NOT CITED] [OLD Version]
  23. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. PMID: 22592739 [NOT CITED] [OLD Version]
  24. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 27820955 [NOT CITED] [LATEST Version]
  25. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 25431975 [NOT CITED] [OLD Version]
  26. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 22696329 [NOT CITED] [OLD Version]
  27. Antioxidant micronutrients for lung disease in cystic fibrosis. PMID: 21154377 [NOT CITED] [LATEST Version]
  28. Antioxidant supplementation for lung disease in cystic fibrosis. PMID: 31580490 [NOT CITED] [LATEST Version]
  29. Antioxidant supplementation for lung disease in cystic fibrosis. PMID: 25102015 [CITED] [OLD Version] [UPDATE NEEDED]
  30. Appetite stimulants for people with cystic fibrosis. PMID: 25064192 [NOT CITED] [LATEST Version]
  31. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. PMID: 28102546 [NOT CITED] [LATEST Version]
  32. Autogenic drainage for airway clearance in cystic fibrosis. PMID: 28984368 [NOT CITED] [LATEST Version]
  33. Bisphosphonates for osteoporosis in people with cystic fibrosis. PMID: 24627308 [CITED] [LATEST Version]
  34. Bisphosphonates for osteoporosis in people with cystic fibrosis. PMID: 22513903 [NOT CITED] [OLD Version]
  35. Bisphosphonates for osteoporosis in people with cystic fibrosis. PMID: 19821288 [NOT CITED] [OLD Version]
  36. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis. PMID: 30221745 [NOT CITED] [LATEST Version]
  37. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis. PMID: 26797965 [NOT CITED] [OLD Version]
  38. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis. PMID: 24363033 [NOT CITED] [OLD Version]
  39. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis. PMID: 23235645 [CITED] [LATEST Version]
  40. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis. PMID: 19370689 [NOT CITED] [OLD Version]
  41. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. PMID: 26688006 [CITED] [LATEST Version]
  42. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. PMID: 24006212 [NOT CITED] [OLD Version]
  43. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. PMID: 28628280 [NOT CITED] [LATEST Version]
  44. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. PMID: 26522473 [NOT CITED] [OLD Version]
  45. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis. PMID: 30070364 [NOT CITED] [LATEST Version]
  46. Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis. PMID: 22972107 [NOT CITED] [LATEST Version]
  47. Dornase alfa for cystic fibrosis. PMID: 30187450 [NOT CITED] [LATEST Version]
  48. Dornase alfa for cystic fibrosis. PMID: 27043279 [NOT CITED] [OLD Version]
  49. Dornase alfa for cystic fibrosis. PMID: 20238314 [NOT CITED] [OLD Version]
  50. Drug therapies for reducing gastric acidity in people with cystic fibrosis. PMID: 27546383 [NOT CITED] [LATEST Version]
  51. Drug therapies for reducing gastric acidity in people with cystic fibrosis. PMID: 25019293 [NOT CITED] [OLD Version]
  52. Drug therapies for reducing gastric acidity in people with cystic fibrosis. PMID: 22513912 [NOT CITED] [OLD Version]
  53. Duration of intravenous antibiotic therapy in people with cystic fibrosis. PMID: 31487382 [NOT CITED] [LATEST Version]
  54. Duration of intravenous antibiotic therapy in people with cystic fibrosis. PMID: 27582394 [NOT CITED] [OLD Version]
  55. Duration of intravenous antibiotic therapy in people with cystic fibrosis. PMID: 23728662 [NOT CITED] [OLD Version]
  56. Duration of intravenous antibiotic therapy in people with cystic fibrosis. PMID: 21249681 [NOT CITED] [OLD Version]
  57. Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis. PMID: 22786481 [NOT CITED] [LATEST Version]
  58. Enteral tube feeding for cystic fibrosis. PMID: 31328789 [NOT CITED] [LATEST Version]
  59. Enteral tube feeding for cystic fibrosis. PMID: 25854213 [NOT CITED] [OLD Version]
  60. Enteral tube feeding for cystic fibrosis. PMID: 23235579 [NOT CITED] [OLD Version]
  61. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis. PMID: 30997925 [NOT CITED] [LATEST Version]
  62. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis. PMID: 27804115 [NOT CITED] [OLD Version]
  63. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis. PMID: 25342425 [NOT CITED] [OLD Version]
  64. Home versus hospital intravenous antibiotic therapy for cystic fibrosis. PMID: 26671062 [NOT CITED] [LATEST Version]
  65. Home versus hospital intravenous antibiotic therapy for cystic fibrosis. PMID: 22419283 [NOT CITED] [OLD Version]
  66. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. PMID: 29921013 [NOT CITED] [LATEST Version]
  67. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. PMID: 26559561 [NOT CITED] [OLD Version]
  68. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. PMID: 24323825 [NOT CITED] [OLD Version]
  69. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis. PMID: 29607494 [NOT CITED] [LATEST Version]
  70. Inhaled antibiotics for long-term therapy in cystic fibrosis. PMID: 21412868 [CITED] [LATEST Version]
  71. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. PMID: 30376155 [NOT CITED] [LATEST Version]
  72. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. PMID: 23235659 [NOT CITED] [OLD Version]
  73. Inhaled corticosteroids for cystic fibrosis. PMID: 31271656 [NOT CITED] [LATEST Version]
  74. Inhaled corticosteroids for cystic fibrosis. PMID: 27552284 [CITED] [OLD Version] [UPDATE NEEDED]
  75. Inhaled corticosteroids for cystic fibrosis. PMID: 25300165 [NOT CITED] [OLD Version]
  76. Inhaled corticosteroids for cystic fibrosis. PMID: 23152209 [NOT CITED] [OLD Version]
  77. Inhaled mannitol for cystic fibrosis. PMID: 29424930 [NOT CITED] [LATEST Version]
  78. Inhaled mannitol for cystic fibrosis. PMID: 26451533 [NOT CITED] [OLD Version]
  79. Inspiratory muscle training for cystic fibrosis. PMID: 24258092 [NOT CITED] [LATEST Version]
  80. Insulin and oral agents for managing cystic fibrosis-related diabetes. PMID: 27087121 [CITED] [LATEST Version]
  81. Insulin and oral agents for managing cystic fibrosis-related diabetes. PMID: 23893261 [NOT CITED] [OLD Version]
  82. Interventions for preventing and managing advanced liver disease in cystic fibrosis. PMID: 28850173 [NOT CITED] [LATEST Version]
  83. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. PMID: 29894558 [NOT CITED] [LATEST Version]
  84. Interventions for promoting participation in shared decision-making for children and adolescents with cystic fibrosis. PMID: 31119726 [NOT CITED] [LATEST Version]
  85. Interventions for promoting physical activity in people with cystic fibrosis. PMID: 24338214 [NOT CITED] [LATEST Version]
  86. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. PMID: 23450608 [NOT CITED] [LATEST Version]
  87. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. PMID: 30030966 [NOT CITED] [LATEST Version]
  88. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. PMID: 25927091 [NOT CITED] [OLD Version]
  89. Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. PMID: 30075058 [NOT CITED] [LATEST Version]
  90. Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis. PMID: 26226131 [NOT CITED] [LATEST Version]
  91. Long-acting inhaled bronchodilators for cystic fibrosis. PMID: 29253920 [NOT CITED] [LATEST Version]
  92. Macrolide antibiotics for cystic fibrosis. PMID: 23152214 [NOT CITED] [LATEST Version]
  93. Macrolide antibiotics for cystic fibrosis. PMID: 22161368 [NOT CITED] [OLD Version]
  94. Nebulised hypertonic saline for cystic fibrosis. PMID: 30260472 [NOT CITED] [LATEST Version]
  95. Nebuliser systems for drug delivery in cystic fibrosis. PMID: 23633344 [NOT CITED] [LATEST Version]
  96. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. PMID: 23852992 [NOT CITED] [LATEST Version]
  97. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. PMID: 26905631 [NOT CITED] [LATEST Version]
  98. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. PMID: 24515341 [NOT CITED] [OLD Version]
  99. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. PMID: 20238363 [NOT CITED] [OLD Version]
  100. Non-invasive ventilation for cystic fibrosis. PMID: 28218802 [CITED] [LATEST Version]
  101. Non-invasive ventilation for cystic fibrosis. PMID: 23633308 [NOT CITED] [OLD Version]
  102. Omega-3 fatty acids for cystic fibrosis. PMID: 26730723 [NOT CITED] [LATEST Version]
  103. Omega-3 fatty acids for cystic fibrosis. PMID: 24282091 [NOT CITED] [OLD Version]
  104. Omega-3 fatty acids for cystic fibrosis. PMID: 21833942 [NOT CITED] [OLD Version]
  105. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. PMID: 31483853 [NOT CITED] [LATEST Version]
  106. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. PMID: 28349527 [NOT CITED] [OLD Version]
  107. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. PMID: 24497229 [NOT CITED] [OLD Version]
  108. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. PMID: 22336782 [NOT CITED] [OLD Version]
  109. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. PMID: 20091528 [NOT CITED] [OLD Version]
  110. Oral anti-pseudomonal antibiotics for cystic fibrosis. PMID: 27412131 [NOT CITED] [LATEST Version]
  111. Oral anti-pseudomonal antibiotics for cystic fibrosis. PMID: 24170644 [NOT CITED] [OLD Version]
  112. Oral calorie supplements for cystic fibrosis. PMID: 28470972 [NOT CITED] [LATEST Version]
  113. Oral calorie supplements for cystic fibrosis. PMID: 25363148 [NOT CITED] [OLD Version]
  114. Oral calorie supplements for cystic fibrosis. PMID: 23076887 [NOT CITED] [OLD Version]
  115. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. PMID: 31499593 [NOT CITED] [LATEST Version]
  116. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. PMID: 27055154 [NOT CITED] [OLD Version]
  117. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. PMID: 23765216 [NOT CITED] [OLD Version]
  118. Oral steroids for long-term use in cystic fibrosis. PMID: 26649765 [NOT CITED] [LATEST Version]
  119. Oral steroids for long-term use in cystic fibrosis. PMID: 23794322 [NOT CITED] [OLD Version]
  120. Oral steroids for long-term use in cystic fibrosis. PMID: 21975730 [NOT CITED] [OLD Version]
  121. Oscillating devices for airway clearance in people with cystic fibrosis. PMID: 28471492 [NOT CITED] [LATEST Version]
  122. Oscillating devices for airway clearance in people with cystic fibrosis. PMID: 25038719 [NOT CITED] [OLD Version]
  123. Oxygen therapy for cystic fibrosis. PMID: 23888484 [NOT CITED] [LATEST Version]
  124. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. PMID: 27439110 [NOT CITED] [LATEST Version]
  125. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. PMID: 24851825 [NOT CITED] [OLD Version]
  126. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. PMID: 23737087 [NOT CITED] [OLD Version]
  127. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. PMID: 22336832 [NOT CITED] [OLD Version]
  128. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. PMID: 20166098 [NOT CITED] [OLD Version]
  129. Palliative drug treatments for breathlessness in cystic fibrosis. PMID: 28795404 [NOT CITED] [LATEST Version]
  130. Pancreatic enzyme replacement therapy for people with cystic fibrosis. PMID: 27878805 [CITED] [LATEST Version]
  131. Pancreatic enzyme replacement therapy for people with cystic fibrosis. PMID: 25310479 [NOT CITED] [OLD Version]
  132. Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis. PMID: 21069703 [NOT CITED] [LATEST Version]
  133. Physical exercise training for cystic fibrosis. PMID: 29090734 [CITED] [LATEST Version]
  134. Physical exercise training for cystic fibrosis. PMID: 26116828 [NOT CITED] [OLD Version]
  135. Pneumococcal vaccines for cystic fibrosis. PMID: 27654832 [NOT CITED] [LATEST Version]
  136. Pneumococcal vaccines for cystic fibrosis. PMID: 25093421 [CITED] [OLD Version] [UPDATE NEEDED]
  137. Pneumococcal vaccines for cystic fibrosis. PMID: 22972126 [NOT CITED] [OLD Version]
  138. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. PMID: 26083308 [CITED] [LATEST Version]
  139. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. PMID: 30616300 [NOT CITED] [LATEST Version]
  140. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. PMID: 25811419 [NOT CITED] [OLD Version]
  141. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. PMID: 29537064 [NOT CITED] [LATEST Version]
  142. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. PMID: 26264938 [NOT CITED] [OLD Version]
  143. Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults. PMID: 26270620 [NOT CITED] [LATEST Version]
  144. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. PMID: 28417451 [NOT CITED] [LATEST Version]
  145. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. PMID: 25419599 [NOT CITED] [OLD Version]
  146. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. PMID: 23235585 [NOT CITED] [OLD Version]
  147. Psychological interventions for individuals with cystic fibrosis and their families. PMID: 24941199 [NOT CITED] [LATEST Version]
  148. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. PMID: 30557452 [NOT CITED] [LATEST Version]
  149. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. PMID: 25991406 [NOT CITED] [OLD Version]
  150. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. PMID: 23737090 [NOT CITED] [OLD Version]
  151. Respiratory muscle training for cystic fibrosis. PMID: 29797578 [NOT CITED] [LATEST Version]
  152. Self-management education for cystic fibrosis. PMID: 25198249 [NOT CITED] [LATEST Version]
  153. Self-management education for cystic fibrosis. PMID: 21735415 [NOT CITED] [OLD Version]
  154. Singing as an adjunct therapy for children and adults with cystic fibrosis. PMID: 31425607 [NOT CITED] [LATEST Version]
  155. Singing as an adjunct therapy for children and adults with cystic fibrosis. PMID: 27629557 [NOT CITED] [OLD Version]
  156. Singing as an adjunct therapy for children and adults with cystic fibrosis. PMID: 24913722 [NOT CITED] [OLD Version]
  157. Singing for children and adults with cystic fibrosis. PMID: 20464761 [NOT CITED] [LATEST Version]
  158. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis. PMID: 27907224 [NOT CITED] [LATEST Version]
  159. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. PMID: 24788768 [NOT CITED] [LATEST Version]
  160. Sodium channel blockers for cystic fibrosis. PMID: 24715704 [NOT CITED] [LATEST Version]
  161. Sodium channel blockers for cystic fibrosis. PMID: 22419304 [NOT CITED] [OLD Version]
  162. Standard (head-down tilt) versus modified (without head-down tilt) postural drainage in infants and young children with cystic fibrosis. PMID: 29684249 [NOT CITED] [LATEST Version]
  163. Standard (head-down tilt) versus modified (without head-down tilt) postural drainage in infants and young children with cystic fibrosis. PMID: 25756796 [NOT CITED] [OLD Version]
  164. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. PMID: 28981972 [NOT CITED] [LATEST Version]
  165. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. PMID: 25741986 [NOT CITED] [OLD Version]
  166. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. PMID: 23152277 [NOT CITED] [OLD Version]
  167. Timing of dornase alfa inhalation for cystic fibrosis. PMID: 30480755 [NOT CITED] [LATEST Version]
  168. Timing of dornase alfa inhalation for cystic fibrosis. PMID: 27457496 [NOT CITED] [OLD Version]
  169. Timing of dornase alfa inhalation for cystic fibrosis. PMID: 23737088 [NOT CITED] [OLD Version]
  170. Timing of dornase alfa inhalation for cystic fibrosis. PMID: 21563162 [NOT CITED] [OLD Version]
  171. Timing of hypertonic saline inhalation for cystic fibrosis. PMID: 28146603 [NOT CITED] [LATEST Version]
  172. Timing of hypertonic saline inhalation for cystic fibrosis. PMID: 22336853 [NOT CITED] [OLD Version]
  173. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. PMID: 27314455 [CITED] [LATEST Version]
  174. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. PMID: 24282073 [NOT CITED] [OLD Version]
  175. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. PMID: 23076917 [NOT CITED] [OLD Version]
  176. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. PMID: 26098667 [NOT CITED] [LATEST Version]
  177. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. PMID: 23633352 [NOT CITED] [OLD Version]
  178. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. PMID: 21563167 [NOT CITED] [OLD Version]
  179. Totally implantable vascular access devices for cystic fibrosis. PMID: 22592694 [NOT CITED] [LATEST Version]
  180. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis. PMID: 30052271 [NOT CITED] [LATEST Version]
  181. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis. PMID: 27003247 [NOT CITED] [OLD Version]
  182. Ursodeoxycholic acid for cystic fibrosis-related liver disease. PMID: 28891588 [CITED] [LATEST Version]
  183. Ursodeoxycholic acid for cystic fibrosis-related liver disease. PMID: 25501301 [NOT CITED] [OLD Version]
  184. Ursodeoxycholic acid for cystic fibrosis-related liver disease. PMID: 23076885 [NOT CITED] [OLD Version]
  185. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis. PMID: 26298311 [NOT CITED] [LATEST Version]
  186. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.. PMID: 23771707 [NOT CITED] [LATEST Version]
  187. Vaccines for preventing influenza in people with cystic fibrosis. PMID: 24604671 [CITED] [LATEST Version]
  188. Vaccines for preventing influenza in people with cystic fibrosis. PMID: 19821281 [NOT CITED] [OLD Version]
  189. Vitamin A and beta (β)-carotene supplementation for cystic fibrosis. PMID: 30091146 [NOT CITED] [LATEST Version]
  190. Vitamin A supplementation for cystic fibrosis. PMID: 24823814 [NOT CITED] [LATEST Version]
  191. Vitamin A supplementation for cystic fibrosis. PMID: 22895955 [NOT CITED] [OLD Version]
  192. Vitamin D supplementation for cystic fibrosis. PMID: 24823922 [CITED] [LATEST Version]
  193. Vitamin D supplementation for cystic fibrosis. PMID: 22513949 [NOT CITED] [OLD Version]
  194. Vitamin D supplementation for cystic fibrosis. PMID: 19821402 [NOT CITED] [OLD Version]
  195. Vitamin E supplementation in people with cystic fibrosis. PMID: 28262916 [NOT CITED] [LATEST Version]
  196. Vitamin E supplementation in people with cystic fibrosis. PMID: 25489958 [NOT CITED] [OLD Version]
  197. Vitamin K supplementation for cystic fibrosis. PMID: 28829533 [NOT CITED] [LATEST Version]
  198. Vitamin K supplementation for cystic fibrosis. PMID: 25879106 [NOT CITED] [OLD Version]
  199. Vitamin K supplementation for cystic fibrosis. PMID: 23633357 [NOT CITED] [OLD Version]
  200. Vitamin K supplementation for cystic fibrosis. PMID: 21249710 [NOT CITED] [OLD Version]
36 Q203601 Pneumothorax Pneumothorax GA 2-High

Pulmonology
  1. Active chest compression-decompression for cardiopulmonary resuscitation. PMID: 24052483 [NOT CITED] [LATEST Version]
  2. Active chest compression-decompression for cardiopulmonary resuscitation. PMID: 15106176 [NOT CITED] [OLD Version]
  3. Active chest compression-decompression for cardiopulmonary resuscitation. PMID: 12137656 [NOT CITED] [OLD Version]
  4. Active chest compression-decompression for cardiopulmonary resuscitation. PMID: 11687024 [NOT CITED] [OLD Version]
  5. Animal derived surfactant extract for treatment of respiratory distress syndrome. PMID: 19370695 [NOT CITED] [LATEST Version]
  6. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. PMID: 26301526 [NOT CITED] [LATEST Version]
  7. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. PMID: 26009996 [NOT CITED] [OLD Version]
  8. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. PMID: 27960245 [NOT CITED] [LATEST Version]
  9. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. PMID: 22696334 [NOT CITED] [OLD Version]
  10. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. PMID: 11687053 [NOT CITED] [OLD Version]
  11. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis. PMID: 23235645 [NOT CITED] [LATEST Version]
  12. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis. PMID: 19370689 [NOT CITED] [OLD Version]
  13. Conservative versus interventional management for primary spontaneous pneumothorax in adults. PMID: 25519778 [CITED] [LATEST Version]
  14. Continuous distending airway pressure for respiratory distress syndrome in preterm infants. PMID: 10908543 [NOT CITED] [LATEST Version]
  15. Continuous distending pressure for respiratory distress in preterm infants. PMID: 26141572 [NOT CITED] [LATEST Version]
  16. Continuous distending pressure for respiratory distress syndrome in preterm infants. PMID: 12076445 [NOT CITED] [LATEST Version]
  17. Continuous distending pressure for respiratory distress syndrome in preterm infants. PMID: 11034747 [NOT CITED] [OLD Version]
  18. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. PMID: 30701528 [NOT CITED] [LATEST Version]
  19. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. PMID: 25563827 [NOT CITED] [OLD Version]
  20. Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation. PMID: 28075489 [NOT CITED] [LATEST Version]
  21. Cromolyn sodium for the prevention of chronic lung disease in preterm infants. PMID: 11406065 [NOT CITED] [LATEST Version]
  22. Deoxyribonuclease for cystic fibrosis. PMID: 10796748 [NOT CITED] [LATEST Version]
  23. Dexamethasone as an adjuvant to peripheral nerve block. PMID: 29121400 [NOT CITED] [LATEST Version]
  24. Early introduction of lipids to parenterally-fed preterm infants. PMID: 15846747 [NOT CITED] [LATEST Version]
  25. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. PMID: 12076469 [NOT CITED] [LATEST Version]
  26. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. PMID: 15266470 [NOT CITED] [LATEST Version]
  27. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. PMID: 17943779 [NOT CITED] [LATEST Version]
  28. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. PMID: 12076463 [NOT CITED] [LATEST Version]
  29. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. PMID: 23152207 [NOT CITED] [LATEST Version]
  30. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. PMID: 10796266 [NOT CITED] [OLD Version]
  31. Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term. PMID: 11279696 [NOT CITED] [LATEST Version]
  32. Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term. PMID: 10796213 [NOT CITED] [OLD Version]
  33. Frequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newborns. PMID: 26945780 [NOT CITED] [LATEST Version]
  34. High flow nasal cannula for respiratory support in preterm infants. PMID: 26899543 [NOT CITED] [LATEST Version]
  35. High-flow nasal cannulae for respiratory support in adult intensive care patients. PMID: 28555461 [NOT CITED] [LATEST Version]
  36. Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in adults without acute lung injury. PMID: 29985541 [NOT CITED] [LATEST Version]
  37. Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in patients without acute lung injury. PMID: 26641378 [NOT CITED] [LATEST Version]
  38. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. PMID: 28141899 [NOT CITED] [LATEST Version]
  39. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. PMID: 12535424 [NOT CITED] [OLD Version]
  40. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. PMID: 10796280 [NOT CITED] [OLD Version]
  41. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. PMID: 21735428 [NOT CITED] [LATEST Version]
  42. Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adult patients. PMID: 24979320 [NOT CITED] [LATEST Version]
  43. Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adults. PMID: 30536850 [NOT CITED] [LATEST Version]
  44. Lung lavage for meconium aspiration syndrome in newborn infants. PMID: 23633311 [NOT CITED] [LATEST Version]
  45. Lung volume reduction surgery for diffuse emphysema. PMID: 10796577 [NOT CITED] [LATEST Version]
  46. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. PMID: 12519575 [NOT CITED] [LATEST Version]
  47. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. PMID: 12535400 [NOT CITED] [LATEST Version]
  48. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. PMID: 11279705 [NOT CITED] [OLD Version]
  49. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. PMID: 10796416 [NOT CITED] [OLD Version]
  50. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. PMID: 10796305 [NOT CITED] [LATEST Version]
  51. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. PMID: 19160177 [NOT CITED] [LATEST Version]
  52. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. PMID: 11405951 [NOT CITED] [LATEST Version]
  53. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. PMID: 10796308 [NOT CITED] [OLD Version]
  54. Needle aspiration versus intercostal tube drainage for pneumothorax in the newborn. PMID: 30707441 [NOT CITED] [LATEST Version]
  55. Needle aspiration versus intercostal tube drainage for pneumothorax in the newborn. PMID: 26751585 [NOT CITED] [OLD Version]
  56. Neurally adjusted ventilatory assist compared to other forms of triggered ventilation for neonatal respiratory support. PMID: 29077984 [NOT CITED] [LATEST Version]
  57. Neuromuscular paralysis for newborn infants receiving mechanical ventilation. PMID: 15846639 [NOT CITED] [LATEST Version]
  58. Neuromuscular paralysis for newborn infants receiving mechanical ventilation. PMID: 11034760 [NOT CITED] [OLD Version]
  59. Non-invasive ventilation for cystic fibrosis. PMID: 28218802 [NOT CITED] [LATEST Version]
  60. Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery. PMID: 26436599 [NOT CITED] [LATEST Version]
  61. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome. PMID: 23881653 [NOT CITED] [LATEST Version]
  62. Point-of-care ultrasonography for diagnosing thoracoabdominal injuries in patients with blunt trauma. PMID: 30548249 [NOT CITED] [LATEST Version]
  63. Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants. PMID: 23943189 [NOT CITED] [LATEST Version]
  64. Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants. PMID: 17943755 [NOT CITED] [LATEST Version]
  65. Postnatal phenobarbitone for the prevention of intraventricular hemorrhage in preterm infants. PMID: 11279724 [NOT CITED] [LATEST Version]
  66. Postnatal phenobarbitone for the prevention of intraventricular hemorrhage in preterm infants. PMID: 10796443 [NOT CITED] [OLD Version]
  67. Preoperative physical therapy for elective cardiac surgery patients. PMID: 23152283 [NOT CITED] [LATEST Version]
  68. Preoxygenation for tracheal suctioning in intubated, ventilated newborn infants. PMID: 11686960 [NOT CITED] [LATEST Version]
  69. Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters. PMID: 22513957 [NOT CITED] [LATEST Version]
  70. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. PMID: 10796380 [NOT CITED] [LATEST Version]
  71. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. PMID: 20091513 [NOT CITED] [LATEST Version]
  72. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. PMID: 10796410 [NOT CITED] [LATEST Version]
  73. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. PMID: 10796379 [NOT CITED] [LATEST Version]
  74. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. PMID: 11405966 [NOT CITED] [LATEST Version]
  75. Prostacyclin for pulmonary arterial hypertension. PMID: 31042010 [NOT CITED] [LATEST Version]
  76. Rescue high frequency oscillatory ventilation versus conventional ventilation for pulmonary dysfunction in preterm infants. PMID: 10796364 [NOT CITED] [LATEST Version]
  77. Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults. PMID: 28881006 [CITED] [LATEST Version]
  78. Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults. PMID: 17253510 [NOT CITED] [OLD Version]
  79. Surfactant for meconium aspiration syndrome in full term infants. PMID: 10796463 [NOT CITED] [LATEST Version]
  80. Surfactant for meconium aspiration syndrome in full term/near term infants. PMID: 17636695 [NOT CITED] [LATEST Version]
  81. Surfactant for meconium aspiration syndrome in term and late preterm infants. PMID: 25504256 [NOT CITED] [LATEST Version]
  82. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. PMID: 23543527 [NOT CITED] [LATEST Version]
  83. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. PMID: 18254035 [NOT CITED] [OLD Version]
  84. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. PMID: 12917997 [NOT CITED] [OLD Version]
  85. Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. PMID: 28707404 [NOT CITED] [LATEST Version]
  86. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 27581993 [NOT CITED] [LATEST Version]
  87. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 27539719 [NOT CITED] [OLD Version]
  88. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 18253979 [NOT CITED] [OLD Version]
  89. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 15494996 [NOT CITED] [OLD Version]
  90. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 11279692 [NOT CITED] [OLD Version]
  91. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 10796368 [NOT CITED] [OLD Version]
  92. Synthetic surfactant for respiratory distress syndrome in preterm infants. PMID: 10796417 [NOT CITED] [LATEST Version]
  93. Techniques to ascertain correct endotracheal tube placement in neonates. PMID: 25217732 [NOT CITED] [LATEST Version]
  94. Ultrasound guidance for upper and lower limb blocks. PMID: 26361135 [NOT CITED] [LATEST Version]
  95. Ultrasound use for the placement of haemodialysis catheters. PMID: 22071820 [NOT CITED] [LATEST Version]
  96. Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports. PMID: 27544827 [NOT CITED] [LATEST Version]
  97. Volume-targeted versus pressure-limited ventilation in neonates. PMID: 29039883 [NOT CITED] [LATEST Version]
  98. Volume-targeted versus pressure-limited ventilation in the neonate. PMID: 21069677 [NOT CITED] [LATEST Version]
  99. Volume-targeted versus pressure-limited ventilation in the neonate. PMID: 16034906 [NOT CITED] [OLD Version]
88 Q105688 hypoxia Hypoxia (medical) C 2-High

Pulmonology
  1. Ambulatory oxygen for chronic obstructive pulmonary disease. PMID: 12076387 [NOT CITED] [LATEST Version]
  2. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. PMID: 24957353 [NOT CITED] [LATEST Version]
  3. Antibiotics for community-acquired pneumonia in children. PMID: 20238334 [NOT CITED] [LATEST Version]
  4. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. PMID: 27574910 [NOT CITED] [LATEST Version]
  5. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. PMID: 20091653 [NOT CITED] [OLD Version]
  6. Cardiotocography for antepartum fetal assessment. PMID: 10796239 [NOT CITED] [LATEST Version]
  7. Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing. PMID: 28125772 [NOT CITED] [LATEST Version]
  8. Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing. PMID: 22336808 [NOT CITED] [OLD Version]
  9. Cerebral near-infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults. PMID: 29341066 [NOT CITED] [LATEST Version]
  10. Continuous positive airway pressure (CPAP) during the postoperative period for prevention of postoperative morbidity and mortality following major abdominal surgery. PMID: 25081420 [NOT CITED] [LATEST Version]
  11. Continuous positive airways pressure for obstructive sleep apnoea in adults. PMID: 16855960 [NOT CITED] [LATEST Version]
  12. Continuous positive airways pressure for obstructive sleep apnoea in adults. PMID: 16437429 [NOT CITED] [OLD Version]
  13. Continuous positive airways pressure for obstructive sleep apnoea. PMID: 12076402 [NOT CITED] [LATEST Version]
  14. Continuous positive airways pressure for obstructive sleep apnoea. PMID: 10796595 [NOT CITED] [OLD Version]
  15. Cooling for cerebral protection during brain surgery. PMID: 25626888 [NOT CITED] [LATEST Version]
  16. Cooling for newborns with hypoxic ischaemic encephalopathy. PMID: 23440789 [NOT CITED] [LATEST Version]
  17. Cooling for newborns with hypoxic ischaemic encephalopathy. PMID: 17943788 [NOT CITED] [OLD Version]
  18. Cooling for newborns with hypoxic ischaemic encephalopathy. PMID: 14583966 [NOT CITED] [OLD Version]
  19. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 12535393 [NOT CITED] [LATEST Version]
  20. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 10796514 [NOT CITED] [OLD Version]
  21. Droperidol for psychosis-induced aggression or agitation. PMID: 27976370 [NOT CITED] [LATEST Version]
  22. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. PMID: 26058966 [NOT CITED] [LATEST Version]
  23. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. PMID: 19588382 [NOT CITED] [LATEST Version]
  24. Gene therapy for peripheral arterial disease. PMID: 30380135 [NOT CITED] [LATEST Version]
  25. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes. PMID: 27404120 [NOT CITED] [LATEST Version]
  26. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes. PMID: 22786520 [NOT CITED] [OLD Version]
  27. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. PMID: 18254121 [NOT CITED] [LATEST Version]
  28. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs. PMID: 28653390 [NOT CITED] [LATEST Version]
  29. Kinesthetic stimulation for treating apnea in preterm infants. PMID: 10796212 [NOT CITED] [LATEST Version]
  30. Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adult patients. PMID: 24979320 [NOT CITED] [LATEST Version]
  31. Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adults. PMID: 30536850 [NOT CITED] [LATEST Version]
  32. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. PMID: 12804388 [NOT CITED] [LATEST Version]
  33. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. PMID: 10796307 [NOT CITED] [OLD Version]
  34. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. PMID: 10908461 [NOT CITED] [OLD Version]
  35. Nitric oxide for respiratory failure in infants born at or near term. PMID: 28056166 [NOT CITED] [LATEST Version]
  36. Nitric oxide for respiratory failure in infants born at or near term. PMID: 17054129 [NOT CITED] [OLD Version]
  37. Nitric oxide for respiratory failure in infants born at or near term. PMID: 11687078 [NOT CITED] [OLD Version]
  38. Nitric oxide for respiratory failure in infants born at or near term. PMID: 11405963 [NOT CITED] [OLD Version]
  39. Nitric oxide for respiratory failure in infants born at or near term. PMID: 10796358 [NOT CITED] [OLD Version]
  40. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome. PMID: 23881653 [NOT CITED] [LATEST Version]
  41. Permissive hypoxaemia versus normoxaemia for mechanically ventilated critically ill patients. PMID: 24801519 [NOT CITED] [LATEST Version]
  42. Phosphodiesterase 5 inhibitors for pulmonary hypertension. PMID: 30701543 [NOT CITED] [LATEST Version]
  43. Physical training for interstitial lung disease. PMID: 18843713 [NOT CITED] [LATEST Version]
  44. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants. PMID: 29303230 [NOT CITED] [LATEST Version]
  45. Pulmonary rehabilitation for interstitial lung disease. PMID: 25284270 [NOT CITED] [LATEST Version]
  46. Pulse oximeters to self monitor oxygen saturation levels as part of a personalised asthma action plan for people with asthma. PMID: 26410043 [NOT CITED] [LATEST Version]
  47. Targeted therapy for advanced renal cell carcinoma. PMID: 18425931 [NOT CITED] [LATEST Version]
  48. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. PMID: 28976555 [NOT CITED] [LATEST Version]
  49. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. PMID: 17054153 [NOT CITED] [OLD Version]
  50. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. PMID: 12137652 [NOT CITED] [OLD Version]
  51. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. PMID: 11687021 [NOT CITED] [OLD Version]
  52. The use of propofol for procedural sedation in emergency departments. PMID: 26222247 [NOT CITED] [LATEST Version]
  53. Tracheal suctioning without disconnection in intubated ventilated neonates. PMID: 22161374 [NOT CITED] [LATEST Version]
  54. Tracheal suctioning without disconnection in intubated ventilated neonates. PMID: 11406066 [NOT CITED] [OLD Version]
  55. Universal neonatal hearing screening versus selective screening as part of the management of childhood deafness. PMID: 15846679 [NOT CITED] [LATEST Version]
  56. Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation. PMID: 27844477 [NOT CITED] [LATEST Version]
3262 Q5558337 Giant-cell carcinoma of the lung Giant-cell carcinoma of the lung C 3-Mid

Hematology-oncology

Pulmonology

 No matching publication found!
12853 Q1153419 interstitial lung disease Interstitial lung disease Start 3-Mid

Pulmonology
  1. Ambulatory and short-burst oxygen for interstitial lung disease. PMID: 27383922 [NOT CITED] [LATEST Version]
  2. Corticosteroids for pulmonary sarcoidosis. PMID: 10796598 [NOT CITED] [OLD Version]
  3. Corticosteroids for pulmonary sarcoidosis. PMID: 11034698 [NOT CITED] [LATEST Version]
  4. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. PMID: 29297205 [NOT CITED] [LATEST Version]
  5. Domiciliary oxygen for interstitial lung disease. PMID: 11687030 [NOT CITED] [LATEST Version]
  6. Nebulised morphine for severe interstitial lung disease. PMID: 12137662 [NOT CITED] [LATEST Version]
  7. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. PMID: 18425927 [NOT CITED] [LATEST Version]
  8. Physical training for interstitial lung disease. PMID: 18843713 [NOT CITED] [LATEST Version]
  9. Pulmonary rehabilitation for interstitial lung disease. PMID: 25284270 [CITED] [LATEST Version]
3361 Q754031 atelectasis Atelectasis Start 3-Mid

Pulmonology
  1. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. PMID: 26833493 [NOT CITED] [LATEST Version]
  2. Chest physiotherapy for preventing morbidity in babies being extubated from mechanical ventilation. PMID: 12076390 [NOT CITED] [LATEST Version]
  3. Chest physiotherapy for preventing morbidity in babies being extubated from mechanical ventilation. PMID: 10796192 [NOT CITED] [OLD Version]
  4. Chest physiotherapy for reducing respiratory morbidity in infants requiring ventilatory support. PMID: 18646156 [NOT CITED] [LATEST Version]
  5. Continuous positive airway pressure (CPAP) during the postoperative period for prevention of postoperative morbidity and mortality following major abdominal surgery. PMID: 25081420 [NOT CITED] [LATEST Version]
  6. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. PMID: 12076463 [NOT CITED] [LATEST Version]
  7. High-flow nasal cannulae for respiratory support in adult intensive care patients. PMID: 28555461 [NOT CITED] [LATEST Version]
  8. Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft. PMID: 17636760 [NOT CITED] [LATEST Version]
  9. Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery. PMID: 19588380 [NOT CITED] [LATEST Version]
  10. Intravenous dexamethasone for extubation of newborn infants. PMID: 11687075 [NOT CITED] [LATEST Version]
  11. Intravenous dexamethasone for extubation of newborn infants. PMID: 10796193 [NOT CITED] [OLD Version]
  12. Nasal versus oral intubation for mechanical ventilation of newborn infants. PMID: 10796391 [NOT CITED] [LATEST Version]
  13. Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months. PMID: 23152257 [NOT CITED] [LATEST Version]
  14. Nitrous oxide-based techniques versus nitrous oxide-free techniques for general anaesthesia. PMID: 26545294 [NOT CITED] [LATEST Version]
  15. Positive end-expiratory pressure (PEEP) during anaesthesia for prevention of mortality and postoperative pulmonary complications. PMID: 24919591 [NOT CITED] [LATEST Version]
  16. Positive end-expiratory pressure (PEEP) during anaesthesia for the prevention of mortality and postoperative pulmonary complications. PMID: 20824871 [NOT CITED] [LATEST Version]
  17. Preoperative exercise training for patients with non-small cell lung cancer. PMID: 28589547 [NOT CITED] [LATEST Version]
  18. Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery. PMID: 26436600 [NOT CITED] [LATEST Version]
  19. Preoperative physical therapy for elective cardiac surgery patients. PMID: 23152283 [NOT CITED] [LATEST Version]
  20. Splenectomy for people with thalassaemia major or intermedia. PMID: 31529486 [NOT CITED] [LATEST Version]
  21. Splenectomy for people with thalassaemia major or intermedia. PMID: 27296775 [NOT CITED] [OLD Version]
3362 Q754348 infant respiratory distress syndrome Infant respiratory distress syndrome C 3-Mid

Pulmonology
  1. Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes. PMID: 24659357 [NOT CITED] [LATEST Version]
3699 Q2012642 cryptogenic organizing pneumonia Cryptogenic organizing pneumonia Start 3-Mid

Pathology

Pulmonology

 No matching publication found!
4514 Q1128595 pulmonary hypertension Pulmonary hypertension B 3-Mid

Cardiology

Pulmonology
  1. Anticoagulation therapy versus placebo for pulmonary hypertension. PMID: 24887213 [NOT CITED] [LATEST Version]
  2. Calcium channel blockers for pulmonary arterial hypertension. PMID: 26407098 [NOT CITED] [LATEST Version]
  3. Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants. PMID: 27535894 [NOT CITED] [LATEST Version]
  4. Endothelin receptor antagonists for pulmonary arterial hypertension. PMID: 23450552 [NOT CITED] [LATEST Version]
  5. Endothelin receptor antagonists for pulmonary arterial hypertension. PMID: 19588356 [NOT CITED] [OLD Version]
  6. Endothelin receptor antagonists for pulmonary arterial hypertension. PMID: 16856046 [NOT CITED] [OLD Version]
  7. Endothelin receptor antagonists for pulmonary arterial hypertension. PMID: 15674947 [NOT CITED] [OLD Version]
  8. Exercise-based rehabilitation programmes for pulmonary hypertension. PMID: 28099988 [NOT CITED] [LATEST Version]
  9. Guanylate cyclase stimulators for pulmonary hypertension. PMID: 27482837 [NOT CITED] [LATEST Version]
  10. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. PMID: 16437478 [NOT CITED] [LATEST Version]
  11. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. PMID: 12804505 [NOT CITED] [OLD Version]
  12. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. PMID: 12804469 [NOT CITED] [LATEST Version]
  13. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. PMID: 18254020 [NOT CITED] [LATEST Version]
  14. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. PMID: 16235321 [NOT CITED] [OLD Version]
  15. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. PMID: 24991723 [NOT CITED] [LATEST Version]
  16. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. PMID: 16235391 [NOT CITED] [OLD Version]
  17. Lung lavage for meconium aspiration syndrome in newborn infants. PMID: 23633311 [NOT CITED] [LATEST Version]
  18. Magnesium sulfate for persistent pulmonary hypertension of the newborn. PMID: 17636807 [NOT CITED] [LATEST Version]
  19. Milrinone for persistent pulmonary hypertension of the newborn. PMID: 21069698 [NOT CITED] [LATEST Version]
  20. Nitric oxide for respiratory failure in infants born at or near term. PMID: 28056166 [NOT CITED] [LATEST Version]
  21. Nitric oxide for respiratory failure in infants born at or near term. PMID: 17054129 [NOT CITED] [OLD Version]
  22. Nitric oxide for respiratory failure in infants born at or near term. PMID: 11687078 [NOT CITED] [OLD Version]
  23. Nitric oxide for respiratory failure in infants born at or near term. PMID: 11405963 [NOT CITED] [OLD Version]
  24. Phosphodiesterase 5 inhibitors for pulmonary hypertension. PMID: 30701543 [NOT CITED] [LATEST Version]
  25. Prenatal interventions for congenital diaphragmatic hernia for improving outcomes. PMID: 26611822 [NOT CITED] [LATEST Version]
  26. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). PMID: 30376188 [NOT CITED] [LATEST Version]
  27. Prostacyclin for pulmonary hypertension in adults. PMID: 15846646 [NOT CITED] [LATEST Version]
  28. Prostacyclin for pulmonary hypertension. PMID: 12804447 [NOT CITED] [LATEST Version]
  29. Prostacyclin for pulmonary hypertension. PMID: 12137667 [NOT CITED] [OLD Version]
  30. Prostaglandins before caesarean section for preventing neonatal respiratory distress. PMID: 24218013 [NOT CITED] [LATEST Version]
  31. Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates. PMID: 31573068 [NOT CITED] [LATEST Version]
  32. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. PMID: 27198469 [NOT CITED] [LATEST Version]
  33. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. PMID: 24399756 [NOT CITED] [OLD Version]
  34. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. PMID: 21901721 [NOT CITED] [OLD Version]
  35. Sildenafil for pulmonary hypertension in neonates. PMID: 28777888 [NOT CITED] [LATEST Version]
  36. Sildenafil for pulmonary hypertension in neonates. PMID: 21833954 [NOT CITED] [OLD Version]
  37. Sildenafil for pulmonary hypertension in neonates. PMID: 17636802 [NOT CITED] [OLD Version]
  38. Sildenafil for pulmonary hypertension. PMID: 15495058 [NOT CITED] [LATEST Version]
  39. Thrombolytic therapy for pulmonary embolism. PMID: 30560579 [NOT CITED] [LATEST Version]
  40. Thrombolytic therapy for pulmonary embolism. PMID: 26419832 [NOT CITED] [OLD Version]
3767 Q922640 bronchopulmonary dysplasia Bronchopulmonary dysplasia Start 3-Mid

Pulmonology
  1. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. PMID: 16855973 [NOT CITED] [LATEST Version]
  2. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. PMID: 11405998 [NOT CITED] [OLD Version]
  3. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. PMID: 10796271 [NOT CITED] [OLD Version]
  4. Air versus oxygen for resuscitation of infants at birth. PMID: 15846632 [NOT CITED] [LATEST Version]
  5. Air versus oxygen for resuscitation of infants at birth. PMID: 15266466 [NOT CITED] [OLD Version]
  6. Albumin infusion for low serum albumin in preterm newborn infants. PMID: 15266522 [NOT CITED] [LATEST Version]
  7. Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants. PMID: 26630252 [NOT CITED] [LATEST Version]
  8. Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome. PMID: 25361381 [NOT CITED] [LATEST Version]
  9. Animal derived surfactant extract for treatment of respiratory distress syndrome. PMID: 19370695 [NOT CITED] [LATEST Version]
  10. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. PMID: 26301526 [NOT CITED] [LATEST Version]
  11. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. PMID: 26009996 [NOT CITED] [OLD Version]
  12. Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants. PMID: 26998583 [NOT CITED] [LATEST Version]
  13. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. PMID: 11687053 [NOT CITED] [LATEST Version]
  14. Continuous distending pressure for respiratory distress in preterm infants. PMID: 26141572 [NOT CITED] [LATEST Version]
  15. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. PMID: 18254092 [NOT CITED] [LATEST Version]
  16. Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. PMID: 17054219 [NOT CITED] [LATEST Version]
  17. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. PMID: 18843729 [NOT CITED] [LATEST Version]
  18. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. PMID: 11869608 [NOT CITED] [LATEST Version]
  19. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. PMID: 10908511 [NOT CITED] [OLD Version]
  20. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. PMID: 10796274 [NOT CITED] [OLD Version]
  21. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. PMID: 29063585 [CITED] [LATEST Version]
  22. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. PMID: 16856062 [NOT CITED] [LATEST Version]
  23. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. PMID: 12076469 [NOT CITED] [LATEST Version]
  24. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. PMID: 15266470 [NOT CITED] [LATEST Version]
  25. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. PMID: 17943779 [NOT CITED] [LATEST Version]
  26. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. PMID: 12076463 [NOT CITED] [LATEST Version]
  27. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. PMID: 23152207 [NOT CITED] [LATEST Version]
  28. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. PMID: 10796266 [NOT CITED] [OLD Version]
  29. Flow-cycled versus time-cycled synchronized ventilation for neonates. PMID: 20614468 [NOT CITED] [LATEST Version]
  30. Fluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infants. PMID: 21735414 [NOT CITED] [LATEST Version]
  31. Fluid restriction for treatment of preterm infants with chronic lung disease. PMID: 28176308 [NOT CITED] [LATEST Version]
  32. Frequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newborns. PMID: 26945780 [NOT CITED] [LATEST Version]
  33. Heparin for the prevention of intraventricular haemorrhage in preterm infants. PMID: 27148674 [NOT CITED] [LATEST Version]
  34. High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants. PMID: 28898404 [NOT CITED] [LATEST Version]
  35. Immunoglobulin for preventing respiratory syncytial virus infection. PMID: 10796658 [NOT CITED] [LATEST Version]
  36. Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/ chronic lung disease. PMID: 16856077 [NOT CITED] [LATEST Version]
  37. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 28045472 [NOT CITED] [LATEST Version]
  38. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 21154346 [NOT CITED] [OLD Version]
  39. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 17636641 [NOT CITED] [OLD Version]
  40. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 16437426 [NOT CITED] [OLD Version]
  41. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 11687084 [NOT CITED] [OLD Version]
  42. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 11686963 [NOT CITED] [OLD Version]
  43. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 10796215 [NOT CITED] [OLD Version]
  44. Inhaled steroids for neonatal chronic lung disease. PMID: 10908553 [NOT CITED] [LATEST Version]
  45. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. PMID: 29041034 [NOT CITED] [LATEST Version]
  46. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants. PMID: 29035425 [NOT CITED] [LATEST Version]
  47. Inositol for respiratory distress syndrome in preterm infants. PMID: 22419275 [NOT CITED] [LATEST Version]
  48. Inositol for respiratory distress syndrome in preterm infants. PMID: 14583919 [NOT CITED] [OLD Version]
  49. Inositol for respiratory distress syndrome in preterm infants. PMID: 11034685 [NOT CITED] [OLD Version]
  50. Inositol for respiratory distress syndrome in preterm infants. PMID: 10796200 [NOT CITED] [OLD Version]
  51. Inositol in preterm infants at risk for or having respiratory distress syndrome. PMID: 31283839 [NOT CITED] [LATEST Version]
  52. Inositol in preterm infants at risk for or having respiratory distress syndrome. PMID: 25927089 [NOT CITED] [OLD Version]
  53. Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants. PMID: 29431872 [NOT CITED] [LATEST Version]
  54. Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns. PMID: 20091659 [NOT CITED] [LATEST Version]
  55. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. PMID: 23821390 [NOT CITED] [LATEST Version]
  56. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. PMID: 14973955 [NOT CITED] [LATEST Version]
  57. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. PMID: 11405962 [NOT CITED] [OLD Version]
  58. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. PMID: 10796199 [NOT CITED] [OLD Version]
  59. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. PMID: 11034718 [NOT CITED] [LATEST Version]
  60. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. PMID: 10796264 [NOT CITED] [OLD Version]
  61. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. PMID: 21735428 [NOT CITED] [LATEST Version]
  62. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. PMID: 29063594 [CITED] [LATEST Version]
  63. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. PMID: 28836266 [NOT CITED] [LATEST Version]
  64. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. PMID: 22513906 [NOT CITED] [OLD Version]
  65. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. PMID: 16856064 [NOT CITED] [LATEST Version]
  66. Lipid emulsions for parenterally fed preterm infants. PMID: 31158919 [NOT CITED] [LATEST Version]
  67. Long versus short inspiratory times in neonates receiving mechanical ventilation. PMID: 15495117 [NOT CITED] [LATEST Version]
  68. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. PMID: 29125893 [NOT CITED] [LATEST Version]
  69. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. PMID: 19160177 [NOT CITED] [LATEST Version]
  70. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. PMID: 11405951 [NOT CITED] [LATEST Version]
  71. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome. PMID: 23076945 [NOT CITED] [LATEST Version]
  72. Neurally adjusted ventilatory assist compared to other forms of triggered ventilation for neonatal respiratory support. PMID: 29077984 [NOT CITED] [LATEST Version]
  73. Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants. PMID: 25418278 [NOT CITED] [LATEST Version]
  74. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. PMID: 21412918 [NOT CITED] [LATEST Version]
  75. Positive end expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia. PMID: 22258957 [NOT CITED] [LATEST Version]
  76. Positive end-expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia. PMID: 30820939 [NOT CITED] [LATEST Version]
  77. Prophylactic methylxanthines for endotracheal extubation in preterm infants. PMID: 21154342 [NOT CITED] [LATEST Version]
  78. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. PMID: 27315509 [NOT CITED] [LATEST Version]
  79. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. PMID: 10796380 [NOT CITED] [LATEST Version]
  80. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. PMID: 20091513 [NOT CITED] [LATEST Version]
  81. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. PMID: 18254095 [NOT CITED] [LATEST Version]
  82. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. PMID: 10796410 [NOT CITED] [LATEST Version]
  83. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. PMID: 10796379 [NOT CITED] [LATEST Version]
  84. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. PMID: 11405966 [NOT CITED] [LATEST Version]
  85. Prostaglandins before caesarean section for preventing neonatal respiratory distress. PMID: 24218013 [NOT CITED] [LATEST Version]
  86. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. PMID: 25473815 [NOT CITED] [LATEST Version]
  87. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. PMID: 18253981 [NOT CITED] [OLD Version]
  88. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. PMID: 11686962 [NOT CITED] [OLD Version]
  89. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. PMID: 10796373 [NOT CITED] [OLD Version]
  90. Sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants. PMID: 25633155 [NOT CITED] [LATEST Version]
  91. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. PMID: 11279743 [NOT CITED] [LATEST Version]
  92. Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes. PMID: 28707404 [NOT CITED] [LATEST Version]
  93. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 27581993 [NOT CITED] [LATEST Version]
  94. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 27539719 [NOT CITED] [OLD Version]
  95. Synchronized mechanical ventilation for respiratory support in newborn infants. PMID: 18253979 [NOT CITED] [OLD Version]
  96. Synthetic surfactant for respiratory distress syndrome in preterm infants. PMID: 10796417 [NOT CITED] [LATEST Version]
  97. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. PMID: 28141913 [NOT CITED] [LATEST Version]
  98. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. PMID: 12519545 [NOT CITED] [LATEST Version]
  99. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. PMID: 10796372 [NOT CITED] [OLD Version]
  100. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. PMID: 17943744 [NOT CITED] [LATEST Version]
  101. Volume-targeted versus pressure-limited ventilation in neonates. PMID: 29039883 [NOT CITED] [LATEST Version]
  102. Volume-targeted versus pressure-limited ventilation in the neonate. PMID: 21069677 [NOT CITED] [LATEST Version]
  103. Volume-targeted versus pressure-limited ventilation in the neonate. PMID: 16034906 [NOT CITED] [OLD Version]
4522 Q1131786 cor pulmonale Pulmonary heart disease C 3-Mid

Cardiology

Pulmonology
  1. Endothelin receptor antagonists for pulmonary arterial hypertension. PMID: 16856046 [NOT CITED] [LATEST Version]
  2. Hydralazine in infants with persistent hypoxemic respiratory failure. PMID: 23450605 [NOT CITED] [LATEST Version]
4063 Q2290446 idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis C 3-Mid

Pulmonology
  1. Ambulatory and short-burst oxygen for interstitial lung disease. PMID: 27383922 [NOT CITED] [LATEST Version]
  2. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. PMID: 27764523 [NOT CITED] [LATEST Version]
  3. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. PMID: 20091630 [NOT CITED] [OLD Version]
  4. Corticosteroids for idiopathic pulmonary fibrosis. PMID: 12917934 [NOT CITED] [LATEST Version]
  5. Immunomodulatory agents for idiopathic pulmonary fibrosis. PMID: 12917947 [NOT CITED] [LATEST Version]
  6. Nebulised morphine for severe interstitial lung disease. PMID: 12137662 [NOT CITED] [LATEST Version]
  7. Non-steroid agents for idiopathic pulmonary fibrosis. PMID: 20824834 [CITED] [LATEST Version]
  8. Physical training for interstitial lung disease. PMID: 18843713 [NOT CITED] [LATEST Version]
  9. Pulmonary rehabilitation for interstitial lung disease. PMID: 25284270 [NOT CITED] [LATEST Version]
  10. Respiratory muscle training in children and adults with neuromuscular disease. PMID: 31487757 [NOT CITED] [LATEST Version]
4404 Q2603200 viral pneumonia Viral pneumonia C 3-Mid

Pulmonology

 No matching publication found!
4563 Q35890 extrinsic allergic alveolitis Hypersensitivity pneumonitis Start 3-Mid

Pulmonology

 No matching publication found!
3016 Q7135955 parasitic pneumonia Parasitic pneumonia Stub 3-Mid

Pulmonology

 No matching publication found!
4555 Q32446 pulmonary fibrosis Pulmonary fibrosis C 3-Mid

Pulmonology
  1. Ambulatory and short-burst oxygen for interstitial lung disease. PMID: 27383922 [NOT CITED] [LATEST Version]
  2. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. PMID: 27764523 [NOT CITED] [LATEST Version]
  3. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. PMID: 20091630 [NOT CITED] [OLD Version]
  4. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. PMID: 26333656 [NOT CITED] [LATEST Version]
  5. Corticosteroids for idiopathic pulmonary fibrosis. PMID: 12917934 [NOT CITED] [LATEST Version]
  6. Domiciliary oxygen for interstitial lung disease. PMID: 11687030 [NOT CITED] [LATEST Version]
  7. Immunomodulatory agents for idiopathic pulmonary fibrosis. PMID: 12917947 [NOT CITED] [LATEST Version]
  8. Nebulised morphine for severe interstitial lung disease. PMID: 12137662 [NOT CITED] [LATEST Version]
  9. Non-steroid agents for idiopathic pulmonary fibrosis. PMID: 20824834 [NOT CITED] [LATEST Version]
  10. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. PMID: 17443585 [NOT CITED] [LATEST Version]
  11. Physical training for interstitial lung disease. PMID: 18843713 [NOT CITED] [LATEST Version]
  12. Pulmonary rehabilitation for interstitial lung disease. PMID: 25284270 [NOT CITED] [LATEST Version]
  13. Respiratory muscle training in children and adults with neuromuscular disease. PMID: 31487757 [NOT CITED] [LATEST Version]
  14. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. PMID: 28084646 [NOT CITED] [LATEST Version]
3753 Q19000410 adenosquamous cell lung carcinoma Adenosquamous lung carcinoma C 3-Mid

Hematology-oncology

Pathology

Pulmonology

 No matching publication found!
3012 Q7132981 Papillary adenocarcinoma Papillary adenocarcinoma Stub 3-Mid

Hematology-oncology

Pulmonology

 No matching publication found!
14 Q200781 pleural empyema Pleural empyema C 3-Mid

Pulmonology
  1. Surgical versus non-surgical management for pleural empyema. PMID: 28304084 [CITED] [LATEST Version]
  2. Surgical versus non-surgical management of pleural empyema. PMID: 16235291 [NOT CITED] [LATEST Version]
  3. Surgical versus non-surgical management of pleural empyema. PMID: 12076430 [NOT CITED] [OLD Version]
2824 Q7320486 rheumatoid lung disease Rheumatoid lung disease Stub 3-Mid

Pulmonology

 No matching publication found!
27 Q103177 severe acute respiratory syndrome Severe acute respiratory syndrome B 3-Mid

Pulmonology
  1. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). PMID: 23076910 [NOT CITED] [LATEST Version]
  2. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). PMID: 16437501 [NOT CITED] [OLD Version]
  3. Interventions for the interruption or reduction of the spread of respiratory viruses. PMID: 17943895 [NOT CITED] [LATEST Version]
  4. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. PMID: 31259389 [NOT CITED] [LATEST Version]
  5. Physical interventions to interrupt or reduce the spread of respiratory viruses. PMID: 21735402 [NOT CITED] [LATEST Version]
  6. Physical interventions to interrupt or reduce the spread of respiratory viruses. PMID: 20091588 [NOT CITED] [OLD Version]
286 Q424227 bronchiolitis Bronchiolitis C 3-Mid

Pulmonology
  1. Anti-cholinergic drugs for wheeze in children under the age of two years. PMID: 10796630 [NOT CITED] [LATEST Version]
  2. Antibiotics for bronchiolitis in children under two years of age. PMID: 25300167 [CITED] [LATEST Version]
  3. Antibiotics for bronchiolitis in children. PMID: 21678346 [NOT CITED] [LATEST Version]
  4. Antibiotics for bronchiolitis in children. PMID: 17253545 [NOT CITED] [OLD Version]
  5. Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. PMID: 28828759 [CITED] [LATEST Version]
  6. Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. PMID: 23235681 [NOT CITED] [OLD Version]
  7. Antibody induction therapy for lung transplant recipients. PMID: 24282128 [NOT CITED] [LATEST Version]
  8. Anticholinergic drugs for wheeze in children under the age of two years. PMID: 16034861 [NOT CITED] [LATEST Version]
  9. Anticholinergic drugs for wheeze in children under the age of two years. PMID: 11869598 [NOT CITED] [OLD Version]
  10. Bronchodilators for bronchiolitis. PMID: 24937099 [CITED] [LATEST Version]
  11. Bronchodilators for bronchiolitis. PMID: 21154348 [NOT CITED] [OLD Version]
  12. Bronchodilators for bronchiolitis. PMID: 16855963 [NOT CITED] [OLD Version]
  13. Bronchodilators for bronchiolitis. PMID: 10796626 [NOT CITED] [OLD Version]
  14. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. PMID: 26833493 [CITED] [LATEST Version]
  15. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. PMID: 22336805 [NOT CITED] [OLD Version]
  16. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. PMID: 17253527 [NOT CITED] [OLD Version]
  17. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. PMID: 15846736 [NOT CITED] [OLD Version]
  18. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). PMID: 22513932 [NOT CITED] [LATEST Version]
  19. Continuous negative extrathoracic pressure or continuous positive airway pressure compared to conventional ventilation for acute hypoxaemic respiratory failure in children. PMID: 24186774 [NOT CITED] [LATEST Version]
  20. Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. PMID: 18254028 [NOT CITED] [LATEST Version]
  21. Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. PMID: 16034907 [NOT CITED] [OLD Version]
  22. Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. PMID: 12917982 [NOT CITED] [OLD Version]
  23. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. PMID: 30701528 [CITED] [LATEST Version]
  24. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. PMID: 25563827 [NOT CITED] [OLD Version]
  25. Epinephrine for bronchiolitis. PMID: 21678340 [NOT CITED] [LATEST Version]
  26. Epinephrine for bronchiolitis. PMID: 14974006 [NOT CITED] [OLD Version]
  27. Glucocorticoids for acute viral bronchiolitis in infants and young children. PMID: 23733383 [CITED] [LATEST Version]
  28. Glucocorticoids for acute viral bronchiolitis in infants and young children. PMID: 20927740 [NOT CITED] [OLD Version]
  29. Glucocorticoids for acute viral bronchiolitis in infants and young children. PMID: 15266547 [NOT CITED] [OLD Version]
  30. Heliox for croup in children. PMID: 24318607 [NOT CITED] [LATEST Version]
  31. Heliox inhalation therapy for bronchiolitis in infants. PMID: 26384333 [CITED] [LATEST Version]
  32. Heliox inhalation therapy for bronchiolitis in infants. PMID: 20393951 [NOT CITED] [OLD Version]
  33. High-flow nasal cannula therapy for infants with bronchiolitis. PMID: 24442856 [NOT CITED] [LATEST Version]
  34. High-flow nasal cannula therapy for respiratory support in children. PMID: 24604698 [NOT CITED] [LATEST Version]
  35. Immunoglobulin treatment for respiratory syncytial virus infection. PMID: 17054220 [NOT CITED] [LATEST Version]
  36. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. PMID: 17253528 [NOT CITED] [LATEST Version]
  37. Inhaled corticosteroids for subacute cough in children. PMID: 23450591 [NOT CITED] [LATEST Version]
  38. Interventions for managing asthma in pregnancy. PMID: 25331331 [NOT CITED] [LATEST Version]
  39. Leukotriene inhibitors for bronchiolitis in infants and young children. PMID: 25773054 [NOT CITED] [LATEST Version]
  40. Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months. PMID: 23152257 [NOT CITED] [LATEST Version]
  41. Nebulised hypertonic saline solution for acute bronchiolitis in infants. PMID: 29265171 [CITED] [LATEST Version]
  42. Nebulised hypertonic saline solution for acute bronchiolitis in infants. PMID: 23900970 [NOT CITED] [OLD Version]
  43. Nebulized hypertonic saline solution for acute bronchiolitis in infants. PMID: 18843717 [NOT CITED] [LATEST Version]
  44. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age. PMID: 21249676 [NOT CITED] [LATEST Version]
  45. Surfactant therapy for bronchiolitis in critically ill infants. PMID: 26299681 [NOT CITED] [LATEST Version]
  46. Surfactant therapy for bronchiolitis in critically ill infants. PMID: 22972138 [NOT CITED] [OLD Version]
  47. Surfactant therapy for bronchiolitis in critically ill infants. PMID: 16856080 [NOT CITED] [OLD Version]
  48. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. PMID: 23728681 [NOT CITED] [LATEST Version]
358 Q344873 acute respiratory distress syndrome of adults Acute respiratory distress syndrome C 3-Mid

Pulmonology
  1. Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). PMID: 20687093 [NOT CITED] [LATEST Version]
  2. Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS). PMID: 28806480 [NOT CITED] [LATEST Version]
  3. High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome. PMID: 27043185 [NOT CITED] [LATEST Version]
  4. High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome. PMID: 23450549 [NOT CITED] [LATEST Version]
  5. High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome. PMID: 14974056 [NOT CITED] [OLD Version]
  6. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults. PMID: 30677127 [NOT CITED] [LATEST Version]
  7. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. PMID: 12535438 [NOT CITED] [LATEST Version]
  8. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. PMID: 11034763 [NOT CITED] [OLD Version]
  9. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. PMID: 20614430 [NOT CITED] [LATEST Version]
  10. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. PMID: 27347773 [NOT CITED] [LATEST Version]
  11. Lateral positioning for critically ill adult patients. PMID: 27169365 [NOT CITED] [LATEST Version]
  12. Lung protective ventilation strategy for the acute respiratory distress syndrome. PMID: 23450544 [NOT CITED] [LATEST Version]
  13. Lung protective ventilation strategy for the acute respiratory distress syndrome. PMID: 17636739 [NOT CITED] [OLD Version]
  14. Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery. PMID: 26436599 [NOT CITED] [LATEST Version]
  15. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome. PMID: 23881653 [NOT CITED] [LATEST Version]
  16. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome. PMID: 15495062 [NOT CITED] [OLD Version]
  17. Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome. PMID: 23450545 [NOT CITED] [LATEST Version]
  18. Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome. PMID: 15106223 [NOT CITED] [OLD Version]
  19. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. PMID: 15495113 [NOT CITED] [LATEST Version]
  20. Pharmacological agents for adults with acute respiratory distress syndrome. PMID: 31334568 [CITED] [LATEST Version]
  21. Positioning for acute respiratory distress in hospitalised infants and children. PMID: 15846674 [NOT CITED] [OLD Version]
  22. Positioning for acute respiratory distress in hospitalised infants and children. PMID: 22786486 [NOT CITED] [LATEST Version]
  23. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). PMID: 25586462 [NOT CITED] [LATEST Version]
  24. Prone position for acute respiratory failure in adults. PMID: 26561745 [NOT CITED] [LATEST Version]
  25. Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation. PMID: 19370647 [NOT CITED] [LATEST Version]
  26. Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation. PMID: 27855477 [NOT CITED] [LATEST Version]
  27. Ventilation with lower tidal volumes versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome. PMID: 15106222 [NOT CITED] [LATEST Version]
  28. Ventilation with lower tidal volumes versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome. PMID: 12917991 [NOT CITED] [OLD Version]
362 Q448747 alveolitis Alveolitis Start 3-Mid

Pulmonology
  1. Corticosteroids for idiopathic pulmonary fibrosis. PMID: 12917934 [NOT CITED] [LATEST Version]
  2. Nebulised morphine for severe interstitial lung disease. PMID: 12137662 [NOT CITED] [LATEST Version]
645 Q1396859 farmer's lung Farmer's lung Start 3-Mid

Pulmonology

 No matching publication found!
775 Q2979344 aspiration pneumonitis Mendelson's syndrome Start 3-Mid

Pulmonology
  1. Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation. PMID: 26578526 [NOT CITED] [LATEST Version]
  2. Interventions at caesarean section for reducing the risk of aspiration pneumonitis. PMID: 24497372 [NOT CITED] [LATEST Version]
  3. Interventions at caesarean section for reducing the risk of aspiration pneumonitis. PMID: 20091567 [NOT CITED] [OLD Version]
  4. Preoperative carbohydrate treatment for enhancing recovery after elective surgery. PMID: 25121931 [NOT CITED] [LATEST Version]
1029 Q1430844 allergic bronchopulmonary aspergillosis Allergic bronchopulmonary aspergillosis B 3-Mid

Pulmonology
  1. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 29551015 [NOT CITED] [LATEST Version]
  2. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 26545165 [NOT CITED] [OLD Version]
  3. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 24043500 [NOT CITED] [OLD Version]
  4. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 27820955 [NOT CITED] [LATEST Version]
  5. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 25431975 [NOT CITED] [OLD Version]
  6. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 22696329 [NOT CITED] [OLD Version]
  7. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. PMID: 11034746 [NOT CITED] [OLD Version]
  8. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. PMID: 15266440 [NOT CITED] [LATEST Version]
  9. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. PMID: 12917898 [NOT CITED] [OLD Version]
  10. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. PMID: 11687098 [NOT CITED] [OLD Version]
  11. Azoles for allergic bronchopulmonary aspergillosis. PMID: 10908485 [NOT CITED] [LATEST Version]
  12. Macrolide antibiotics for bronchiectasis. PMID: 29543980 [NOT CITED] [LATEST Version]
  13. Oral versus inhaled antibiotics for bronchiectasis. PMID: 29587336 [NOT CITED] [LATEST Version]
1681 Q3508797 Obstructive lung disease Obstructive lung disease Start 3-Mid

Pulmonology
  1. Beclometasone for chronic obstructive pulmonary disease. PMID: 24105424 [NOT CITED] [LATEST Version]
  2. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. PMID: 10796457 [NOT CITED] [LATEST Version]
  3. Cardioselective beta-blocker use in patients with reversible airway disease. PMID: 11406056 [NOT CITED] [LATEST Version]
  4. Cardioselective beta-blockers for chronic obstructive pulmonary disease. PMID: 12076486 [NOT CITED] [LATEST Version]
  5. Cardioselective beta-blockers for reversible airway disease. PMID: 12519582 [NOT CITED] [LATEST Version]
  6. Cardioselective beta-blockers for reversible airway disease. PMID: 11869646 [NOT CITED] [OLD Version]
  7. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD). PMID: 30536566 [NOT CITED] [LATEST Version]
  8. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). PMID: 28185242 [NOT CITED] [LATEST Version]
  9. Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure. PMID: 14584005 [NOT CITED] [LATEST Version]
  10. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. PMID: 28922692 [NOT CITED] [LATEST Version]
1850 Q651223 pneumoconiosis Pneumoconiosis Start 3-Mid

Pulmonology

 No matching publication found!
2951 Q767485 respiratory failure Respiratory failure Start 3-Mid

Pulmonology
  1. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis. PMID: 23737089 [NOT CITED] [LATEST Version]
  2. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis. PMID: 20927769 [NOT CITED] [OLD Version]
  3. Antibiotics for bronchiolitis in children under two years of age. PMID: 25300167 [NOT CITED] [LATEST Version]
  4. Antibiotics for bronchiolitis in children. PMID: 21678346 [NOT CITED] [LATEST Version]
  5. Antibiotics for treating community acquired pneumonia in people with sickle cell disease. PMID: 23076916 [NOT CITED] [LATEST Version]
  6. Antibiotics for treating community-acquired pneumonia in people with sickle cell disease. PMID: 27841444 [NOT CITED] [LATEST Version]
  7. Antithrombin III for critically ill patients. PMID: 26858174 [NOT CITED] [LATEST Version]
  8. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. PMID: 28102546 [NOT CITED] [LATEST Version]
  9. Chest physiotherapy for preventing morbidity in babies being extubated from mechanical ventilation. PMID: 12076390 [NOT CITED] [LATEST Version]
  10. Chest physiotherapy for preventing morbidity in babies being extubated from mechanical ventilation. PMID: 10796192 [NOT CITED] [OLD Version]
  11. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. PMID: 23966133 [NOT CITED] [LATEST Version]
  12. Continuous distending pressure for respiratory distress in preterm infants. PMID: 26141572 [NOT CITED] [LATEST Version]
  13. Continuous distending pressure for respiratory distress syndrome in preterm infants. PMID: 12076445 [NOT CITED] [LATEST Version]
  14. Continuous distending pressure for respiratory distress syndrome in preterm infants. PMID: 11034747 [NOT CITED] [OLD Version]
  15. Continuous negative extrathoracic pressure or continuous positive airway pressure compared to conventional ventilation for acute hypoxaemic respiratory failure in children. PMID: 24186774 [NOT CITED] [LATEST Version]
  16. Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. PMID: 18254028 [NOT CITED] [LATEST Version]
  17. Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. PMID: 16034907 [NOT CITED] [OLD Version]
  18. Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. PMID: 12917982 [NOT CITED] [OLD Version]
  19. Corticosteroids for acute severe asthma in hospitalised patients. PMID: 11279726 [NOT CITED] [LATEST Version]
  20. Corticosteroids for acute severe asthma in hospitalised patients. PMID: 10796664 [NOT CITED] [OLD Version]
  21. Corticosteroids for pneumonia. PMID: 29236286 [NOT CITED] [LATEST Version]
  22. Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation. PMID: 28075489 [NOT CITED] [LATEST Version]
  23. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants. PMID: 27976361 [NOT CITED] [LATEST Version]
  24. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. PMID: 12076469 [NOT CITED] [LATEST Version]
  25. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. PMID: 15266470 [NOT CITED] [LATEST Version]
  26. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. PMID: 17943779 [NOT CITED] [LATEST Version]
  27. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. PMID: 25785789 [NOT CITED] [LATEST Version]
  28. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. PMID: 19588317 [NOT CITED] [OLD Version]
  29. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. PMID: 17636590 [NOT CITED] [OLD Version]
  30. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. PMID: 14583909 [NOT CITED] [OLD Version]
  31. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. PMID: 12535383 [NOT CITED] [OLD Version]
  32. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. PMID: 11686950 [NOT CITED] [OLD Version]
  33. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. PMID: 10796129 [NOT CITED] [OLD Version]
  34. Endovascular treatment for ruptured abdominal aortic aneurysm. PMID: 28548204 [NOT CITED] [LATEST Version]
  35. Endovascular treatment for ruptured abdominal aortic aneurysm. PMID: 25042123 [NOT CITED] [OLD Version]
  36. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. PMID: 26731032 [NOT CITED] [LATEST Version]
  37. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. PMID: 22786494 [NOT CITED] [OLD Version]
  38. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. PMID: 16856074 [NOT CITED] [OLD Version]
  39. Extracorporeal membrane oxygenation for critically ill adults. PMID: 25608845 [NOT CITED] [LATEST Version]
  40. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. PMID: 18646070 [NOT CITED] [LATEST Version]
  41. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. PMID: 11869599 [NOT CITED] [OLD Version]
  42. Heliox for croup in children. PMID: 30371952 [NOT CITED] [LATEST Version]
  43. Heliox for croup in children. PMID: 24318607 [NOT CITED] [OLD Version]
  44. Heliox for croup in children. PMID: 20166089 [NOT CITED] [OLD Version]
  45. Heliox for treatment of exacerbations of chronic obstructive pulmonary disease. PMID: 12076487 [NOT CITED] [LATEST Version]
  46. High frequency oscillatory ventilation versus conventional ventilation for infants with severe pulmonary dysfunction born at or near term. PMID: 19588337 [NOT CITED] [LATEST Version]
  47. High-flow nasal cannulae for respiratory support in adult intensive care patients. PMID: 28555461 [NOT CITED] [LATEST Version]
  48. Hydralazine in infants with persistent hypoxemic respiratory failure. PMID: 23450605 [NOT CITED] [LATEST Version]
  49. Immunomodulatory agents for idiopathic pulmonary fibrosis. PMID: 12917947 [NOT CITED] [LATEST Version]
  50. Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery. PMID: 24510642 [NOT CITED] [LATEST Version]
  51. Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. PMID: 25080126 [NOT CITED] [LATEST Version]
  52. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. PMID: 12535438 [NOT CITED] [LATEST Version]
  53. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. PMID: 11034763 [NOT CITED] [OLD Version]
  54. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. PMID: 20614430 [NOT CITED] [LATEST Version]
  55. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. PMID: 27347773 [NOT CITED] [LATEST Version]
  56. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 28045472 [NOT CITED] [LATEST Version]
  57. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 21154346 [NOT CITED] [OLD Version]
  58. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 17636641 [NOT CITED] [OLD Version]
  59. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 16437426 [NOT CITED] [OLD Version]
  60. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 11687084 [NOT CITED] [OLD Version]
  61. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 11686963 [NOT CITED] [OLD Version]
  62. Inhaled nitric oxide for respiratory failure in preterm infants. PMID: 10796215 [NOT CITED] [OLD Version]
  63. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. PMID: 26171905 [NOT CITED] [LATEST Version]
  64. Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders. PMID: 29199768 [NOT CITED] [LATEST Version]
  65. Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adult patients. PMID: 24979320 [NOT CITED] [LATEST Version]
  66. Long versus short inspiratory times in neonates receiving mechanical ventilation. PMID: 15495117 [NOT CITED] [LATEST Version]
  67. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. PMID: 28982219 [NOT CITED] [LATEST Version]
  68. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. PMID: 23543531 [NOT CITED] [OLD Version]
  69. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. PMID: 19821325 [NOT CITED] [OLD Version]
  70. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. PMID: 12519575 [NOT CITED] [LATEST Version]
  71. Metrifonate for Alzheimer's disease. PMID: 16625573 [NOT CITED] [LATEST Version]
  72. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. PMID: 12804388 [NOT CITED] [LATEST Version]
  73. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. PMID: 10796307 [NOT CITED] [OLD Version]
  74. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. PMID: 10908461 [NOT CITED] [OLD Version]
  75. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. PMID: 28146296 [NOT CITED] [LATEST Version]
  76. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. PMID: 25188554 [NOT CITED] [OLD Version]
  77. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. PMID: 11687052 [NOT CITED] [OLD Version]
  78. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. PMID: 23852992 [NOT CITED] [LATEST Version]
  79. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. PMID: 19160327 [NOT CITED] [OLD Version]
  80. Nitric oxide for respiratory failure in infants born at or near term. PMID: 28056166 [NOT CITED] [LATEST Version]
  81. Nitric oxide for respiratory failure in infants born at or near term. PMID: 17054129 [NOT CITED] [OLD Version]
  82. Nitric oxide for respiratory failure in infants born at or near term. PMID: 11687078 [NOT CITED] [OLD Version]
  83. Nitric oxide for respiratory failure in infants born at or near term. PMID: 11405963 [NOT CITED] [OLD Version]
  84. Nitric oxide for respiratory failure in infants born at or near term. PMID: 10796358 [NOT CITED] [OLD Version]
  85. Non-invasive positive pressure ventilation for acute asthma in children. PMID: 27687114 [NOT CITED] [LATEST Version]
  86. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 14974057 [NOT CITED] [OLD Version]
  87. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 15266518 [NOT CITED] [LATEST Version]
  88. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. PMID: 12535509 [NOT CITED] [OLD Version]
  89. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. PMID: 23235608 [NOT CITED] [LATEST Version]
  90. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. PMID: 16034928 [NOT CITED] [OLD Version]
  91. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. PMID: 15674944 [NOT CITED] [OLD Version]
  92. Non-invasive ventilation for cystic fibrosis. PMID: 28218802 [NOT CITED] [LATEST Version]
  93. Non-invasive ventilation for cystic fibrosis. PMID: 23633308 [NOT CITED] [OLD Version]
  94. Non-invasive ventilation for cystic fibrosis. PMID: 19160211 [NOT CITED] [OLD Version]
  95. Non-invasive ventilation for cystic fibrosis. PMID: 17943773 [NOT CITED] [OLD Version]
  96. Non-invasive ventilation for cystic fibrosis. PMID: 12804435 [NOT CITED] [OLD Version]
  97. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. PMID: 28702957 [NOT CITED] [LATEST Version]
  98. Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure. PMID: 20687075 [NOT CITED] [LATEST Version]
  99. Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure. PMID: 14584005 [NOT CITED] [OLD Version]
  100. Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery. PMID: 26436599 [NOT CITED] [LATEST Version]
  101. Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respiratory failure. PMID: 24323843 [NOT CITED] [LATEST Version]
  102. Oral steroids for cystic fibrosis. PMID: 10796717 [NOT CITED] [LATEST Version]
  103. Oral steroids for long-term use in cystic fibrosis. PMID: 26649765 [NOT CITED] [LATEST Version]
  104. Oral steroids for long-term use in cystic fibrosis. PMID: 23794322 [NOT CITED] [OLD Version]
  105. Oral steroids for long-term use in cystic fibrosis. PMID: 21975730 [NOT CITED] [OLD Version]
  106. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome. PMID: 23881653 [NOT CITED] [LATEST Version]
  107. Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome. PMID: 15495062 [NOT CITED] [OLD Version]
  108. Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome. PMID: 23450545 [NOT CITED] [LATEST Version]
  109. Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome. PMID: 15106223 [NOT CITED] [OLD Version]
  110. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. PMID: 30399208 [NOT CITED] [LATEST Version]
  111. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. PMID: 29618171 [NOT CITED] [OLD Version]
  112. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. PMID: 25923524 [NOT CITED] [OLD Version]
  113. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery. PMID: 23152223 [NOT CITED] [LATEST Version]
  114. Positive end expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia. PMID: 22258957 [NOT CITED] [LATEST Version]
  115. Positive end-expiratory pressure (PEEP) during anaesthesia for the prevention of mortality and postoperative pulmonary complications. PMID: 20824871 [NOT CITED] [LATEST Version]
  116. Positive end-expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia. PMID: 30820939 [NOT CITED] [LATEST Version]
  117. Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants. PMID: 23943189 [NOT CITED] [LATEST Version]
  118. Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants. PMID: 17943755 [NOT CITED] [LATEST Version]
  119. Postnatal phenobarbitone for the prevention of intraventricular hemorrhage in preterm infants. PMID: 11279724 [NOT CITED] [LATEST Version]
  120. Postnatal phenobarbitone for the prevention of intraventricular hemorrhage in preterm infants. PMID: 10796443 [NOT CITED] [OLD Version]
  121. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. PMID: 30616300 [NOT CITED] [LATEST Version]
  122. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. PMID: 25811419 [NOT CITED] [OLD Version]
  123. Pressure support versus T-tube for weaning from mechanical ventilation in adults. PMID: 24865303 [NOT CITED] [LATEST Version]
  124. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). PMID: 25586462 [NOT CITED] [LATEST Version]
  125. Prone position for acute respiratory failure in adults. PMID: 26561745 [NOT CITED] [LATEST Version]
  126. Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation. PMID: 10908519 [NOT CITED] [LATEST Version]
  127. Prophylactic methylxanthine for extubation in preterm infants. PMID: 10796303 [NOT CITED] [LATEST Version]
  128. Prophylactic methylxanthines for endotracheal extubation in preterm infants. PMID: 21154342 [NOT CITED] [LATEST Version]
  129. Prophylactic methylxanthines for extubation in preterm infants. PMID: 12535389 [NOT CITED] [LATEST Version]
  130. Protocolized versus non-protocolized weaning for reducing the duration of invasive mechanical ventilation in newborn infants. PMID: 26998745 [NOT CITED] [LATEST Version]
  131. Rescue high frequency oscillatory ventilation vs conventional ventilation for infants with severe pulmonary dysfunction born at or near term. PMID: 11279790 [NOT CITED] [LATEST Version]
  132. Respiratory muscle training in children and adults with neuromuscular disease. PMID: 31487757 [NOT CITED] [LATEST Version]
  133. Surfactant for meconium aspiration syndrome in full term infants. PMID: 10796463 [NOT CITED] [LATEST Version]
  134. Surfactant for meconium aspiration syndrome in full term/near term infants. PMID: 17636695 [NOT CITED] [LATEST Version]
  135. Surfactant for meconium aspiration syndrome in term and late preterm infants. PMID: 25504256 [NOT CITED] [LATEST Version]
  136. Surfactant therapy for bronchiolitis in critically ill infants. PMID: 26299681 [NOT CITED] [LATEST Version]
  137. Surfactant therapy for bronchiolitis in critically ill infants. PMID: 22972138 [NOT CITED] [OLD Version]
  138. Surfactant therapy for bronchiolitis in critically ill infants. PMID: 16856080 [NOT CITED] [OLD Version]
  139. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. PMID: 26107113 [NOT CITED] [LATEST Version]
  140. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. PMID: 21678379 [NOT CITED] [OLD Version]
  141. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. PMID: 21563158 [NOT CITED] [LATEST Version]
1883 Q3620651 central sleep apnea Central sleep apnea C 3-Mid

Pulmonology

 No matching publication found!
12911 Q55998 pleurisy Pleurisy C 3-Mid

Pulmonology
  1. Corticosteroids for tuberculous pleurisy. PMID: 28290161 [NOT CITED] [LATEST Version]
  2. Corticosteroids for tuberculous pleurisy. PMID: 17943759 [NOT CITED] [OLD Version]
  3. Steroids for treating tuberculous pleurisy. PMID: 10796669 [NOT CITED] [LATEST Version]
2045 Q16606552 obstructive sleep apnea Obstructive sleep apnea B 3-Mid

Pulmonology
  1. Anti-inflammatory medications for obstructive sleep apnea in children. PMID: 21249687 [NOT CITED] [LATEST Version]
2162 Q688890 pulmonary sequestration Pulmonary sequestration Start 3-Mid

Pulmonology

 No matching publication found!
2337 Q4116448 tracheal stenosis Laryngotracheal stenosis Start 3-Mid

Pulmonology

 No matching publication found!
2761 Q1790424 idiopathic interstitial pneumonia Idiopathic interstitial pneumonia Stub 3-Mid

Pulmonology
  1. Nebulised morphine for severe interstitial lung disease. PMID: 12137662 [NOT CITED] [LATEST Version]
1999 Q3776920 bacterial pneumonia Bacterial pneumonia Start 3-Mid

Pulmonology
  1. Antibiotic therapy versus no antibiotic therapy for children aged two to 59 months with WHO-defined non-severe pneumonia and wheeze. PMID: 24859388 [NOT CITED] [LATEST Version]
  2. Antibiotics for bronchiolitis in children under two years of age. PMID: 25300167 [NOT CITED] [LATEST Version]
  3. Antibiotics for bronchiolitis in children. PMID: 21678346 [NOT CITED] [LATEST Version]
  4. Antibiotics for bronchiolitis in children. PMID: 17253545 [NOT CITED] [OLD Version]
  5. Corticosteroids for pneumonia. PMID: 29236286 [NOT CITED] [LATEST Version]
  6. Corticosteroids for preventing postherpetic neuralgia. PMID: 18254083 [NOT CITED] [LATEST Version]
  7. Surfactant for bacterial pneumonia in late preterm and term infants. PMID: 22336836 [NOT CITED] [LATEST Version]
4340 Q2529980 bird fancier's lung Bird fancier's lung Start 4-Low

Pulmonology

 No matching publication found!
3515 Q4866195 Basaloid large cell carcinoma of the lung Basaloid large cell carcinoma of the lung Start 4-Low

Hematology-oncology

Pulmonology

 No matching publication found!
2388 Q17147306 Usual interstitial pneumonia Usual interstitial pneumonia Start 4-Low

Pulmonology
  1. Corticosteroids for idiopathic pulmonary fibrosis. PMID: 12917934 [NOT CITED] [LATEST Version]
  2. Immunomodulatory agents for idiopathic pulmonary fibrosis. PMID: 12917947 [NOT CITED] [LATEST Version]
  3. Nebulised morphine for severe interstitial lung disease. PMID: 12137662 [NOT CITED] [LATEST Version]
2402 Q17155516 Mucinous cystadenocarcinoma of the lung Mucinous cystadenocarcinoma of the lung Start 4-Low

Hematology-oncology

Pulmonology

 No matching publication found!
627 Q2906693 baritosis Baritosis Stub 4-Low

Pulmonology

Toxicology

 No matching publication found!
474 Q246040 congenital cystic adenomatoid malformation Congenital pulmonary airway malformation Start 4-Low

Medical genetics

Pulmonology

 No matching publication found!
2500 Q18345704 pulmonary venoocclusive disease Pulmonary venoocclusive disease C 4-Low

Pulmonology

 No matching publication found!
3172 Q4674171 Acinic cell carcinoma of the lung Acinic cell carcinoma of the lung Stub 4-Low

Hematology-oncology

Pulmonology

 No matching publication found!
3060 Q1878759 lymphangioleiomyomatosis Lymphangioleiomyomatosis C 4-Low

Pulmonology

 No matching publication found!
1856 Q653318 silicosis Silicosis B 4-Low

Dermatology

Pulmonology
  1. Exercise training to improve exercise capacity and quality of life in people with non-malignant dust-related respiratory diseases. PMID: 26544672 [NOT CITED] [LATEST Version]
  2. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. PMID: 23828580 [NOT CITED] [LATEST Version]